Some of my best efforts to help with the current state of general confusion, I hope it works! And if it does, please remember to share it!

I don’t talk much about myself because I don’t want or need to leverage my persona / CV / bio to support anything I say. If my arguments don’t speak for themselves, my CV is useless and it won’t really speak for the facts.

However, this time it’s particularly relevant where this is coming from, because many years ago I was a fake news operative in the country that borders Ukraine to the south. In other words, I was a mainstream news journalist in Romania, a media mercenary, a low/middle echelon disinformation agent exactly like those exposed by Project Veritas.
This was long ago in my life’s timeline, but historically it was yesterday, around the same time Putin was raising to fame. 9/11 caught me at my desk in a radio station’s news dept. I shook hands with all Romanian presidents after Ceausescu, I partied with much of today’s political class there, attended international meetings etc. And today’s Ukraine and its deep state resembles quite a lot 1990’s / early 2k Romania.
This experience offered me not only great deep insights of the system, but also the ability to reverse-engineer news to the point where I can often see the real story behind a propaganda news piece, I can tell what the writer thought doing it, what his editor’s thoughts were and who financed it. Because I played all those positions and more.
I quit all that for an artistic career just the last second before getting completely sucked in for life, I left because I grew disgusted with myself and the people who saw me as their asset. Then I left the country completely.
I am sorry sorry for what I did, but I don’t apologize or excuse myself, instead I just did the work I thought fit to to redeem myself in my own eyes, to fix what I can in this world. Not because I’m a great altruist and I love you so much I lose sleep over it, but because I love myself and I don’t fare well as part of the problem in a slave farm.
This where this work comes from. As for my biases, I’ not a fan of and I have no loyalty to any group of people, the largest the worse, with the exception of music concert and festival audiences. I think all governments are terrorist organizations, all ideologies are dumb BS by their core definition and good people don’t dream of ruling over others or leading them.
And from where I stand, this is what I see:

FULL

A higher resolution downloadable version will be uploaded next days on our Odysee. Feel free to reupload it, I just hope you will link back to the source.

I strongly recommend watching it as I meant it and built it – in one séance, but if you can’t, for whatever reasons…

SPLIT BY CHAPTERS

later fallout

This meme keeps writing itself

(some of the)sources

I will add more soon, it’s a lot of them…

Now, this took a hell lot of effort and time, and I have another one in works that helps understanding how we got here. A prequel, if you wish. It could’ve been done by now, but my equipment is aging fast, its performances are slow and getting slower, while I am refused my normal existence and means to earn it, except for your voluntary donations. So any help is much needed and appreciated these days, many many thanks go to the generous souls that have made this possible so far! It meant something, we’ve already made a serious impact.


Modi: “Post World-Wars, the entire world worked on a New World Order. We need to do it again”

To be continued?
Our work and existence, as media and people, is funded solely by our most generous readers and we want to keep this way.
Help SILVIEW.media survive and grow, please donate here, anything helps. Thank you!

! Articles can always be subject of later editing as a way of perfecting them

This might be the biggest news since Covid and, four days later, no one is talking about it. So big it’s worth sounding war drums to cover it.
Some scientists say it’s a 1/3trillion coincidence, others say it’s nothing amazing. I propose a my own solution to this debate.

The facts:

In a new study, published only four days ago in Frontiers in Virology, researchers compared the SARS-COV-2 makeup to millions of sequenced proteins in a database, finding a coincidence that they deem as a 1/3trillion mathematical probability.
The other element of the coincidence is the notorious Moderna 2016 invention patent for a technology included in a precursor to the Covid mRNA vaccine, the cancer mRNA jab they were working on at the time.

The virus is made up of 30,000 letters of genetic code that carry the information it needs to spread, known as nucleotides.

We’ve discussed this here (long course):

SCIENTIFIC CONSENSUS: WE’VE NEVER SEEN A VIRUS ISOLATE, JUST A MEMO FROM CHINA ON A SERVER

And here (dumbed down course)

WHY THE CHINA LAB LEAK IS JUST ANOTHER BLATANT PSY-OP REINFORCING THE MAIN LIE FOR UTTER MORONS, EXPLAINED TO CHILD-MINDED ADULTS WITH MANY COLORFUL ILLUSTRATIONS

Analysis of the original Covid genome found the virus shares a sequence of 19 specific letters with a genetic section owned by Moderna, which has a total of 3,300 nucleotides.

The few scientists that have reacted to this discovery so far haven’t denied it.
But some denied its importance and relevance, stating simplistically that 19 nucleotides out of 3300 is not much and can be a natural coincidence, possibly driven by common evolutionary needs. Except the patent is not the fruit of natural evolution, it wouldn’t be patentable if it were natural.

Daily Mail reports:

“Twelve of the shared letters make up the structure of Covid’s furin cleavage site, with the rest being a match with nucleotides on a nearby part of the genome. 
Writing in the paper, led by Dr Balamurali Ambati, from the University of Oregon, the researchers said the matching code may have originally been introduced to the Covid genome through infected human cells expressing the MSH3 gene.  
Professor Lawrence Young, a virologist at Warwick University, admitted the latest finding was interesting but claimed it was not significant enough to suggest lab manipulation. He told MailOnline:
‘We’re talking about a very, very, very small piece made up of 19 nucleotides. ‘So it doesn’t mean very much to be frank, if you do these types of searches you can always find matches. ‘Sometimes these things happen fortuitously, sometimes it’s the result of convergent evolution (when organisms evolve independently to have similar traits to adapt to their environment). ‘It’s a quirky observation but I wouldn’t call it a smoking gun because it’s too small. He added: ‘It doesn’t get us any further with the debate about whether Covid was engineered.’  
Dr Simon Clarke, a microbiologist at Reading University, questioned whether the find was as rare as the study claims. He told MailOnline:
‘There can only be a certain number of [genetic combinations within] furin cleavage sites. ‘They function like a lock and key in the cell, and the two only fit together in a limited number of combinations. ‘So it’s an interesting coincidence but this is surely entirely coincidental.’ 

Say what?!?!

“MailOnline has approached Moderna for comment.”

UDATE: Daily Mail couldn’t get a comment from Moderna, but Fox could. And it’s spectacular in its own very special way:

Moderna CEO scrambles to explain their 2016 invention patent containing SARS-Cov-2 elements

And I have reasons to think those guys suck balls and very likely this is the biggest news since Covid, hear me out:

This news is a perfect case study for a point I’ve been making for a long while: things in Universe exist in either of these three states:

  1. Natural occurrence beyond human influence aka COINCIDENCES

2. The aimed result of human deliberation and activity aka CONSPIRACIES.

3. A combination of 1. and 2. aka CONSPIRACIES GONE HAYWIRE, which I think describes 99% of human life experience.

And, based on history, lived or learned, pure coincidences are way more rare than pure conspiracies, or mixtures, so favoring coincidences over conspiracies is simply dumb and ignorant.

Thus,
Coincidence theorists are the ones who deserve the most scrutiny, mockery and ridicule.
In the human society, as opposed to nature, coincidence theories should be more seriously scrutinized than conspiracy theories.

It is crucial to find alternative ways to solve such a debate with means that are accessible to anyone that’s just a functional literate.

THE DISCUSSION

Is that nucleotide sequence a stunningly unlikely coincidence or just nothing special?

“One in three trillion” or “once in a while”?

How do we arbiter this high-expertise debate without having that expertise and without relying on pre-chewed opinions from dubious or biased experts?

I have a bachelor degree in journalism and public communication, and I’ve always been deeply interested in science even since before school. I have studied health (not just medicines) and physiology for my own understanding, use and benefit for over 20 years now. As a result, I haven’t used any medication in close to 15 years now. That’s where expertise ends for me. People with other occupations and passions need to be able to make their own minds on this because ‘expert’ nowadays is the politically correct term for whores.

I can’t calculate complicated probabilities, nor do I have the education and the practical experience of a virologist, as the majority of any media readership. But they don’t have my education either, and I bet you it’s just as useful.

So does this mean we can’t find a way to skin this cat and we have to take these conmen’s word?

Don’t be silly. This is SILVIEW.media

When it comes to chance and ‘probabilistics’, the most common reference is the lottery. Not so popular among the young ones, but I hope they have a grasp of it too. At least through some online games.

There are many models, I don’t play, I’ll just pick one that I remember from home.
It’s called “6 out of 49”. As the name suggest, from the numbers 1-49 they randomly pick 6 and you have to guess all of them. But they give you a decent prize even if you have five matches, because that’s extraordinary enough.


VERY IMPORTANTLY:
1. The order doesn’t matter.
2. The numbers don’t mean anything, they don’t have any function, nor do they make up a system.

There’s been years without any claim for the grand prize there. That’s how rare this coincidences are.

Now, in our dilemma we have a huge stream of only four characters, as the genome is made up of only four nucleobases: guanine, adenine, cytosine and thymine; in RNA, uracil is used in place of thymine.
They are symbolised with the letters A, C, G, T. Not by coincidence, they also form the name Gattaca.

So, in our genetic coincidence theory we have a stream of 3300 of these four elements and another one of 3000, and a fragment of 19 elements coincides between the two streams. Is that so amazing?

Maybe a superficial face value estimate, by the lottery model, “19 out of 3000” sounds insignificant, but that’s the wrong equation here.

Remember:
1. The order
2. The function

It’s not in the numbers, but in the succession and the function

As opposed to lottery, what surprises here is not that we have matching elements, but a massive matching sequence of elements.
That’s a whole new level of complexity.
We’re dealing with a mathematical combination of four elements taken 19 times. Now that mathematical function will yield a gigantic number of possibilities.

And then something takes things to a whole new level: the sequence is not just some random fragment from the character streams, it’s a full subsystem with its own functionality.

Twelve of the shared letters make up the structure of Covid’s furin cleavage site, with the rest being a match with nucleotides on a nearby part of the genome. 

And it’s not just any function, they are debating if this is what makes it more contagious, as in ‘the capabilities they add to viruses through gain-of-function research’!

According to Medical News Today:

  • Scientists do not yet fully understand how individual mutations in SARS-CoV-2 variants influence contagiousness or disease severity.
  • To enter a human cell, the SARS-CoV-2’s spike protein must be activated. This happens following cleavage by an enzyme called furin.
  • Scientists have theorized that mutations at the furin cleavage site might play an important role in a variant’s ability to infect or replicate in human cells.
  • Contrary to expectations, the authors of a new study found that this mutation did not influence the ability of the virus to enter or spread between cells.
  • Some variants of concern, such as Delta and Omicron, also have mutations at the same furin cleavage site, and this study may help understand the changes in their contagiousness and ability to produce disease.

More so, here’s a study titled ‘Furin Cleavage Site Is Key to SARS-CoV-2 Pathogenesis’.

And guess what: The origin of SARS-CoV-2 furin cleavage site remains a mystery.

If it were a random coincidence, it wouldn’t have a meaning / function of its own, it would be… random.

How do you get from:

“Dr Simon Clarke, a microbiologist at Reading University, questioned whether the find was as rare as the study claims. He told MailOnline: ‘There can only be a certain number of [genetic combinations within] furin cleavage sites.
‘They function like a lock and key in the cell, and the two only fit together in a limited number of combinations. “

to:

“So it’s an interesting coincidence but this is surely entirely coincidental.” 

Daily Mail

Absolute non-sequitur. They literally demonstrated the opposite of their conclusion.
They simply count on you not critically analyzing things, just skimming headlines.

Because coincidence theorists are fucking dumb.

I mean, is it even theoretically possible if we factor in all the discussion above? What would be the likeliness? Sounds somewhere in the range of one in trillions to me. I’d personally round it up to an infinite.

While we can’t extract precise numbers with this method of reasoning, we can establish that this is the biggest lottery ticket ever won.

Disclaimer: this article does not imply that SARS-COV-2 exists in any other form and shape than a stream o characters on some computer hard drives. That’s all we’ve seen and analyzed here.

To be continued?
Our work and existence, as media and people, is funded solely by our most generous readers and we want to keep this way.
Help SILVIEW.media survive and grow, please donate here, anything helps. Thank you!

! Articles can always be subject of later editing as a way of perfecting them

ORDER



We warned you that giving these people free access to your body is a bad idea, for they will take advantage to put in and take out all sorts of things you don’t know about. Just like they do with everything else.

If you’ve been around for a while, this doesn’t really surprise you, but it’s a valuable confirmation and we can move over with this discussion.

If not, you definitely need to catch up with this too:

BGI – BILL GATES’ & BIG TECH’S CHINESE DARLINGS: WORLD’S TOP DNA HARVESTERS, CLONERS, UIGHUR PERSECUTERS (BIOHACKING P.4)

To be continued?
Our work and existence, as media and people, is funded solely by our most generous readers and we want to keep this way.
Help SILVIEW.media survive and grow, please donate here, anything helps. Thank you!

! Articles can always be subject of later editing as a way of perfecting them

The Internets got agitated recently at the news that Moderna’s CEO, Stephane Bancel, dumped $400Million in Moderna stocks and nuked his Twitter account. Here’s why this shouldn’t surprise you and you should expect the worst any moment now.

Developing story, to be updated

Have you watched the former Blackrock director that went on Bannon’s War Room and prophesied that the Covid vaccines are a bubble that’s about to pop? Everything I’ve learned lately stands to support his claim.

This is him on Twitter:

If the dumping were a sudden and unusual move, this would indicate a recent event that shook the system, possibly rats leaving a sinking ship, a near threat for the business, as in:

That’s the case only partly, due to the stock crash overlapped with the incoming financial report, but a constant behavior over the span of months and years rather indicate a strategy and it’s associated with insider trading more often than not.

Surprisingly, it’s NPR of all the fakestream media who came in support of my suspicions, with a pretty merciless analysis of Moderna’s leadership financial behavior. And you know what’s funny? The piece dates all the way back to September 2020. I recommend reading the whole piece, I added the bolding and highlights :

Whether the coronavirus vaccine developed by Moderna succeeds or not, executives at the small biotech company have already made tens of millions of dollars by cashing in their stock. An NPR examination of official company disclosures has revealed additional irregularities and potential warning signs.

“On a scale of one to 10, one being less concerned and 10 being the most concerned,” said Daniel Taylor, an associate professor of accounting at the Wharton School, “this is an 11.”

Taylor said Moderna’s stock-selling practices appear well outside the norm, and raise questions about the company’s internal controls to prevent insider trading.

Since January, CEO Stéphane Bancel has sold roughly $40 million worth of Moderna stock held by himself or associated investment funds; Chief Medical Officer Tal Zaks has sold around $60 million; and President Stephen Hoge has sold more than $10 million.

Stéphane Bancel, chief executive officer of Moderna, has sold roughly $40 million worth of stock in the company since the beginning of this year.

The stock sales first came to widespread notice after Moderna announced positive early data from a vaccine trial in May [2020 – S.m.]. At that point, the company’s share price jumped and official disclosures showed executives cashing in their shares for millions of dollars.

“As long as stocks are sold after public announcements – and not before – one might conclude that for an executive with significant net worth tied up in the company, it’s a prudent thing to do,” said Marc Fagel, a former longtime enforcement official with the Securities And Exchange Commission (SEC). “But the optics aren’t great.”

The Moderna vaccine was quick to reach a phase 3 trial, and is seen as a promising contender. But, in some ways, the executives’ stock sales have overshadowed the company’s progress.

Advocates have questioned whether it’s appropriate for executives to privately profit before bringing the vaccine to market, especially when American taxpayers have committed roughly $2.5 billion to the company’s vaccine development and manufacture.

Here’s what NPR’s examination found:

  • Stock Sales Worth Tens Of Millions: Since June 1, NPR has found, company executives have sold roughly $90 million worth of Moderna stock. Rather than put a hold on the trades after facing intense criticism in May, company executives continued to sell.
  • Questionable Modifications To Stock Sale Plans: Moderna says its executives pre-scheduled their stock sales long in advance. Those schedules – known as 10b5-1 plans – can act as a defense to charges of insider trading. But the plans have to be put in place when executives do not have confidential inside information. NPR has found multiple executives adopted or modified their plans just before key announcements about the company’s vaccine. That has raised questions about whether they were aware of nonpublic information when they planned their stock trades.
  • Selling To Zero: Generally, corporate best practices suggest that a company’s leadership should hold on to at least some stock in their company to have “skin in the game.” That way, the thinking goes, an executive has an incentive to improve the company’s performance. As Moderna has been developing its coronavirus vaccine, two executives, including the Chief Medical Officer, have sold all their stock holdings in the company. The General Counsel has sold nearly all of her holdings.

In an interview with NPR, Ray Jordan, Moderna’s Chief Corporate Affairs Officer, said the company has strict internal policies in place to prevent illegal insider trading. For example, Jordan said, the company only allows employees to make changes to their stock sale schedules when they don’t have confidential inside information that could affect the company’s share price.

NPR asked Jordan why Moderna executives modified their 10b5-1 plans just before major announcements. Initially, Jordan said by email, “I believe you must have your dates wrong.”

NPR then provided documentation of those dates from the company’s official disclosures to the government, which Jordan did not dispute.

Jordan then said that even though multiple Moderna executives changed their 10b5-1 plans within one business day of announcements, the company had determined that those executives did not have “material nonpublic information” – a key term for insider trading – when they made those changes.

A spokesperson for the SEC declined to comment for this story.

From a relative unknown, to a key player in the vaccine race

Moderna launched in 2010 with a headquarters based in Cambridge, Mass., focused on using a technology called messenger RNA (or mRNA) to develop vaccines and therapeutics. The mRNA technology has been widely considered innovative, but remains largely unproven. The company has never brought a product to market. In early January, Moderna was trading for under $20 per share, and was valued at around six billion dollars.

Then Moderna announced that it had started collaborating on a coronavirus vaccine with scientists from the National Institute of Allergy and Infectious Diseases, which is led by Dr. Anthony Fauci.

By April, the government had committed half a billion dollars to the Moderna vaccine project as part of Operation Warp Speed.

Since then, the company’s stock price has exploded. Press releases suggesting positive news from the scientific trials, or announcing additional commitments of taxpayer funding sent the share price to a peak of around $95, before dropping to between $60-$70 in recent months. The company is now valued at around $25 billion.

As a result, shares owned by Moderna executives suddenly became much more valuable. And those executives have cashed in tens of millions of dollars worth of stock, according to filings with the SEC.

The bad press and critical comments did not deter continued sales. Since June 1, NPR found, executives sold around $90 million worth of stock.

Public money, private gain

The U.S. government is making massive financial bets on several vaccine candidates. In all likelihood, only some of those vaccine candidates will prove sufficiently safe and effective.

“If the vaccine doesn’t work, you lost a lot of money,” Fauci has said. “But we feel this is serious enough that it’s worth the financial risk.”

But even if taxpayers lose money betting on Moderna, the company’s executives have already made millions.

“The insiders are making plenty of profit and they’re mostly doing it with our money,” said Margarida Jorge, a campaign director with the group Lower Drug Prices Now. “I’m absolutely for deploying public money in the interests of public health and the public good. But we don’t have any commitment from the administration that any of this investment is ultimately going to benefit real people.”

Moderna has argued that the company was only in a position to work with the government on a coronavirus vaccine, because it had spent a decade developing its mRNA technology with the support of private investors.

“The company has been funded over the years by billions of dollars of private investment,” Zaks told the Freakonomics podcast in August. “Those billions created the opportunity for the U.S. government to come in earlier this year and say, ‘I’m going to add some money to the pot to make sure that you get the development for this vaccine right.'”

[But they locked in the Government and its funding for mRNA technology years before SARS-COV2, as shown below, so this was a deliberate lie – S.m]
Trying to resuscitate the company with some archive work?

“Set it and forget it” stock plans

Moderna has offered another defense of those stock sales: the sales, representatives and executives say, were scheduled well in advance, and were unrelated to the market-moving announcements about the coronavirus vaccine. An NPR examination of the company’s financial filings tells a more complicated story.

The schedules are known as 10b5-1 plans. If your stock trades are on autopilot, the idea goes, then you can’t be accused of insider trading. But these “set it and forget it” plans have to be adopted when executives do not have “material nonpublic information,” to use the legal term.

In an interview with CNBC in July, CEO Bancel said he and other executives set up their 10b5-1 plans “a long time ago” – in December 2018 – and “obviously, when we set up those plans, none of us had any idea what was going to happen in 2020.”

In fact, NPR has found, Moderna executives, including Bancel himself, implemented new plans or modified older plans at multiple points in 2020, and right around key announcements related to the company’s vaccine.

On Jan. 21, 2020, for example, Chief Medical Officer Dr. Tal Zaks amended his 10b5-1 plan. (It’s unclear what changes he made.)

Then, on Jan. 22, Moderna first widely confirmed that it was working with the government on a coronavirus vaccine. The following day, Jan. 23, the company announced it had received additional funding to support its coronavirus vaccine development.

NPR asked Moderna whether Zaks might have been aware of the collaboration with the government when he changed his stock trading plan.

“What was known on that particular day or not known, I couldn’t specifically talk to,” Moderna’s Jordan told NPR. But he said that the Moderna legal team only allows employees to change their 10b5-1 plans if they do not possess inside information that could affect the company’s share price.

Later, on Friday, March 13, three Moderna executives adopted new 10b5-1 plans, according to records reviewed by NPR: Zaks, Chief Technical Operations and Quality Officer Juan Andres, and then-Chief Financial Officer Lorence H. Kim. (Kim left the company in August 2020.)

On Monday, March 16 – one business day later – the company announced that it had given a participant the first dose of their vaccine as part of its phase 1 trial. The stock ended that day up 24% compared to the previous day’s close. Moderna was “bucking the trend” of the broader market, which was panicking over coronavirus fears, one CNBC host said at the time.

Timing Of Changes To Pre-Scheduled Stock Sales Raises Questions

Jan. 21 – Chief Medical Officer Dr. Tal Zaks amends his schedule of stock sales, known as a 10b5-1 plan.

Jan. 22 – Moderna widely confirms that it is working on a coronavirus vaccine with the National Institutes of Health. The company’s share price rises nearly 5% over the previous day’s close.

Jan. 23 – Moderna announces new funding from the Coalition for Epidemic Preparedness Innovations.

Mar. 13 – Chief Technical Operations Officer Juan Andres, Chief Financial Officer Lorence Kim, and Zaks adopt new 10b5-1 trading plans.

Mar. 16 – Moderna announces that it provided the first dose of its coronavirus vaccine to a participant in a phase 1 trial. Moderna stock climbs 24% over the previous day’s close.

May 18 – Moderna reports early positive data from its phase 1 trial. The company’s stock ends the day up 20% over the previous day’s close.

May 21 – CEO Stéphane Bancel adopts and amends multiple 10b5-1 trading plans.

May 29 – Moderna announces another milestone in its phase 2 coronavirus vaccine trial.

June 1 – President Stephen Hoge amends his 10b5-1 plan.

Despite the close timing, Jordan told NPR, “by the judgment of the legal team, there would not have been material, nonpublic information known” when executives entered into the new plans.

“Every company and individual is entitled to the presumption of innocence. That said, from the public’s perspective, this trading behavior looks very problematic,” said Taylor of the Wharton School, who first pointed out the timing of these changes to NPR.

“If I put on my SEC enforcement hat, I would certainly be asking, ‘What caused you to change the plan on a Friday?'” said Kurt Wolfe, who works as a defense attorney in securities cases for the firm Troutman Pepper. “I don’t think it’s a good fact pattern.”

On May 21 – in between announcements of major vaccine trial milestones on May 18 and May 29 – CEO Bancel amended and adopted 10b5-1 plans. And on June 1, President Hoge amended his trading plan.

“Amending a trading plan after a positive announcement, like trading after a positive announcement, is only problematic if the executive possesses material, nonpublic information at the time,” said Fagel. “Though repeated or questionably-timed changes to a trading plan will reduce its value as a defense to insider trading.”

Selling to zero

Using these 10b5-1 plans, two Moderna executives – Zaks and Andres – have sold all of their shares in the company. General Counsel Lori Henderson has sold nearly all of her shares.

In fact, roughly every week since June, Zaks has exercised stock options (meaning, he bought stock at a price set by the company as part of his compensation), and then immediately sold all of his shares for a significant profit.

[Isn’t this a great explanation for Bancel’s sales too?! – S.m]


On Aug. 24, for example, Zaks exercised stock options and bought 25,000 shares at bargain prices of between $12 to $21. He then immediately sold all of those shares for around $65 per share. Zaks ended up with a profit of nearly $1.2 million.

SEC filings indicate these trades are made under the 10b5-1 plan he adopted in March.

Selling so much stock can also raise concerns for investors – and the public – about why company leaders would sell now if they expected their vaccine to succeed later. After all, a safe and effective vaccine could send Moderna’s stock to even greater heights.

“It perhaps draws questions about how much they believe in it,” said Wolfe.

If the company does develop a safe and effective coronavirus vaccine, and its stock keeps rising, then “these trades will be water under the bridge,” said Fagel, the former SEC enforcement official.

But, Fagel warns, if the vaccine fails, then SEC regulators and angry investors may come looking for answers. In that case, he said, “both class action litigation and an SEC investigation would seem inevitable.”

NPR revelations end here, we’re actually just starting

So what we’ve learned is that Moderna looks like a stock market operation more than a medical one. The chiefs create momentums and then trade. And they use public money to bet and make billions, but more about that shortly.

This news is actually pretext to get you to know the real history of Moderna, a crux point in modern history in the widest sense. The stock dumping is not really news, it’s been happening for quite a while, indicating a long term strategy and business model, rather than a sudden or impulse move.

The next two older reports from Pharma’s own media – STAT, will cement the certainty that Moderna turned into a stock market bubble long ago, under the helms of Stephan Bancel. They don’t mind having some science to show, but that’s just the bait.

Ego, ambition, and turmoil: Inside one of biotech’s most secretive startups

By Damian Garde for STAT, Sept. 13, 2016

At first glance, Moderna Therapeutics looks like the most enviable biotech startup in the world. It has smashed fundraising records and teamed up with pharmaceutical giants as it pursues a radical plan to revolutionize medicine by transforming human cells into drug factories.

But the reality is more complicated.

A STAT investigation found that the company’s caustic work environment has for years driven away top talent and that behind its obsession with secrecy, there are signs Moderna has run into roadblocks with its most ambitious projects.

At the center of it all is Stéphane Bancel, a first-time biotech CEO with an unwavering belief that Moderna’s science will work — and that employees who don’t “live the mission” have no place in the company. Confident and intense, Bancel told STAT that Moderna’s science is on track and, when it is finally made public, that it will meet the brash goal he himself has set: The new drugs will change the world.

But interviews with more than 20 current and former employees and associates suggest Bancel has hampered progress at Moderna because of his ego, his need to assert control and his impatience with the setbacks that are an inevitable part of scienceModerna is worth more than any other private biotech in the US, and former employees said they felt that Bancel prized the company’s ever-increasing valuation, now approaching $5 billion, over its science.

As he pursued a complex and risky strategy for drug development, Bancel built a culture of recrimination at Moderna, former employees said. Failed experiments have been met with reprimands and even on-the-spot firings. They recalled abusive emails, dressings down at company meetings, exceedingly long hours, and unexplained terminations.

At least a dozen highly placed executives have quit in the past four years, including heads of finance, technology, manufacturing, and science. In just the past 12 months, respected leaders of Moderna’s cancer and rare disease programs both resigned, even though the company’s remarkable fundraising had put ample resources at their disposal. Each had been at the company less than 18 months, and the positions have yet to be filled.

Lower-ranking employees, meanwhile, said they’ve been disappointed and confused by Moderna’s pivot to less ambitious — and less transformative — treatments. Moderna has pushed off projects meant to upend the drug industry to focus first on the less daunting (and most likely, far less lucrative) field of vaccines — though it is years behind competitors in that arena.

The company has published no data supporting its vaunted technology, and it’s so secretive that some job candidates have to sign nondisclosure agreements before they come in to interview. Outside venture capitalists said Moderna has so many investors clamoring to get in that it can afford to turn away any who ask too many questions. Some small players have been given only a peek at Moderna’s data before committing millions to the company, according to people familiar with the matter.

“It’s a case of the emperor’s new clothes,” said a former Moderna scientist. “They’re running an investment firm, and then hopefully it also develops a drug that’s successful.”

Like many employees and former employees, the scientist requested anonymity because of a nondisclosure agreement. Others would not permit their names to be published out of fear that speaking candidly about big players in the industry would hurt their job prospects down the road.

Moderna just moved its first two potential treatments — both vaccines — into human trials. In keeping with the culture of secrecy, though, executives won’t say which diseases the vaccines target, and they have not listed the studies on the public federal registry, ClinicalTrials.gov. Listing is optional for Phase 1 trials, which are meant to determine if a drug is safe, but most companies voluntarily disclose their work.

Investors say it’ll be worth the wait when the company finally lifts the veil.

“We think that when the world does get to see Moderna, they’re going to see something far larger in its scope than anybody’s seen before,” said Peter Kolchinsky, whose RA Capital Management owns a stake in the company.

Moderna
The Moderna offices in Cambridge, Mass.ARAM BOGHOSIAN FOR STAT

Bancel, meanwhile, said he is aware of the criticism of him and has taken some steps to address it. After scathing anonymous comments about Moderna’s management began showing up online, Bancel went to Silicon Valley to get tips on employee retention from the human resources departments of Facebook, Google, and Netflix. But he makes no apologies for tumult past or present, pointing to the thousands of patients who might be saved by Moderna’s technology.

“You want to be the guy who’s going to fail them? I don’t,” he said in an interview from his glassy third-floor office. “So was it an intense place? It was. And do I feel sorry about it? No.”

An ambitious CEO dreams big

Bancel, 44, had no experience running a drug development operation when one of biotech’s most successful venture capitalists tapped him to lead Moderna. He’d spent most of his career in sales and operations, not science.

But he had made no secret of his ambition.

A native of France, Bancel earned a master’s in chemical engineering from the University of Minnesota and an MBA from Harvard in 2000. As Harvard Business School classmates rushed to cash in on the dot-com boom, Bancel laid out a plan to play “chess, not checkers.”

“I was always thinking, one day, somebody will have to make a decision about me getting a CEO job,” he told an audience at his alma mater in April. “… How do I make sure I’m not the bridesmaid? How do I make sure that I’m not always the person who’s almost selected but doesn’t get the role?”

He went into sales and rose through the operational ranks at pharmaceutical giant Eli Lilly, eventually leading the company’s Belgian operation. And in 2007, at just 34, he achieved his goal, stepping in as CEO of the French diagnostics firm bioMérieux, which employs roughly 6,000 people.

The company improved its margins under Bancel’s tenure, and he developed a reputation as a stern manager who got results, according to an equities analyst who covered bioMérieux at the time.

“He doesn’t suffer fools lightly,” the analyst said, speaking on condition of anonymity to comply with company policy. “I think if you’re underperforming, you’ll probably find yourself looking for another job.”

Bancel’s rise caught the eye of the biotech investment firm Flagship Ventures, based here in Cambridge. Flagship CEO Noubar Afeyan repeatedly tried to entice him to take over one of the firm’s many startups, Bancel said. But he rejected one prospect after another because the startups seemed too narrow in scope.

Moderna was different.

The company’s core idea was seductively simple: cut out the middleman in biotech.

For decades, companies have endeavored to craft better and better protein therapies, leading to new treatments for cancer, autoimmune disorders, and rare diseases. Such therapies are costly to produce and have many limitations, but they’ve given rise to a multibillion-dollar industry. The anti-inflammatory Humira, the world’s top drug at $14 billion in sales a year, is a shining example of protein therapy.

Moderna’s technology promised to subvert the whole field, creating therapeutic proteins inside the body instead of in manufacturing plants. The key: harnessing messenger RNA, or mRNA.

In nature, mRNA molecules function like recipe books, directing cellular machinery to make specific proteins. Moderna believes it can play that system to its advantage by using synthetic mRNA to compel cells to produce whichever proteins it chooses. In effect, the mRNA would turn cells into tiny drug factories.

It’s highly risky. Big pharma companies had tried similar work and abandoned it because it’s exceedingly hard to get RNA into cells without triggering nasty side effects. But if Moderna can get it to work, the process could be used to treat scores of diseases, including cancers and rare diseases that can be death sentences for children.

Bancel was intrigued. He knew it was a gamble, he told STAT, “but if I don’t do it, and it works, I’m just going to kick myself every morning.”

And so he became the company’s CEO — and soon developed an almost messianic reverence for the mRNA technology.

Despite having never worked with RNA before, Bancel said he sat around the table with his core team in the early days of the company, dreaming up experiments. As a result, he is listed as a co-inventor on more than 100 of Moderna’s early patent applications, unusual for a CEO who is not a PhD scientist.

Lavishly funded Moderna hits safety problems in bold bid to revolutionize medicine

By Damian Garde, STAT, Jan. 10, 2017

SAN FRANCISCO — Moderna Therapeutics, the most highly valued private company in biotech, has run into troubling safety problems with its most ambitious therapy, STAT has learned — and is now banking on a mysterious new technology to keep afloat its brash promise of reinventing modern medicine.

Exactly one year ago, Moderna CEO Stéphane Bancel talked up his company’s “unbelievable” future before a standing-room-only crowd at the annual J.P. Morgan Healthcare Conference here. He promised that Moderna’s treatment for a rare and debilitating disease known as Crigler-Najjar syndrome, developed alongside biotech giant Alexion Pharmaceuticals, would enter human trials in 2016.

It was to be the first therapy using audacious new technology that Bancel promised would yield dozens of drugs in the coming decade.

But the Crigler-Najjar treatment has been indefinitely delayed, an Alexion spokeswoman told STAT. It never proved safe enough to test in humans, according to several former Moderna employees and collaborators who worked closely on the project. Unable to press forward with that technology, Moderna has had to focus instead on developing a handful of vaccines, turning to a less lucrative field that might not justify the company’s nearly $5 billion valuation.

“It’s all vaccines right now, and vaccines are a loss-leader,” said one former Moderna manager. “Moderna right now is a multibillion-dollar vaccines company, and I don’t see how that holds up.”

Bancel made no mention of the Crigler-Najjar drug when he spoke Monday before a similarly packed room at this year’s J.P. Morgan conference.

His presentation instead focused on four vaccines that the company is moving through the first phase of clinical trials: two target strains of influenza, a third is for Zika virus, and the fourth remains a secret. Bancel clicked through graphs of data from animal studies before hurrying on to tout Moderna’s balance sheet and discuss the company’s cancer vaccines, slated for clinical testing later this year.

When STAT asked Bancel after the presentation about Crigler-Najjar, he deferred to Alexion.

In need of a Hail Mary

Founded in 2012, Moderna reached unicorn status — a $1 billion valuation — in just two years, faster than Uber, Dropbox, and Lyft, according to CB Insights. The company’s premise: Using custom-built strands of messenger RNA, known as mRNA, it aims to turn the body’s cells into ad hoc drug factories, compelling them to produce the proteins needed to treat a wide variety of diseases.

But mRNA is a tricky technology. Several major pharmaceutical companies have tried and abandoned the idea, struggling to get mRNA into cells without triggering nasty side effects.

Bancel has repeatedly promised that Moderna’s new therapies will change the world, but the company has refused to publish any data on its mRNA vehicles, sparking skepticism from some scientists and a chiding from the editors of Nature.

The indefinite delay on the Crigler-Najjar project signals persistent and troubling safety concerns for any mRNA treatment that needs to be delivered in multiple doses, covering almost everything that isn’t a vaccine, former employees and collaborators said.

The company did disclose a new technology on Monday that it says will more safely deliver mRNA. It’s called V1GL. Last month, Bancel told Forbes about another new technology, N1GL.

But in neither case has the company provided any details. And that lack of specificity has inevitably raised questions.

Three former employees and collaborators close to the process said Moderna was always toiling away on new delivery technologies in hopes of hitting on something safer than what it had. (Even Bancel has acknowledged, in an interview with Forbes, that the delivery method used in Moderna’s first vaccines “was not very good.”)

Are N1GL and V1GL better? The company has produced no data to answer that question. When STAT asked about new technologies, Bancel referred questions to the company’s patent filings.

The three former employees and collaborators said they believe N1GL and V1GL are either very recent discoveries, just in the earliest stages of testing — or else new names slapped on technologies Moderna has owned for years.

“[The technology] would have to be a miraculous, Hail Mary sort of save for them to get to where they need to be on their timelines,” one former employee said. “Either [Bancel] is extremely confident that it’s going to work, or he’s getting kind of jittery that with a lack of progress he needs to put something out there.”

Former employees and collaborators who spoke with STAT requested anonymity because they had signed nondisclosure agreements — which the highly secretive Moderna requires even some job candidates to sign.

STAT investigation last year found that Bancel had driven away top talent from Moderna with a culture of recrimination and a caustic work environment, including on-the-spot firings for failed experiments.

The company, based in Cambridge, Mass., seems to have repaired its reputation among many rank-and-file employees, winning workplace accolades from Science Magazine and the Boston Globe, but Moderna has lost more than a dozen top scientists and managers in the past four years, despite its vast financial resources.

A bug in the software

Bancel, a first-time biotech CEO, has dismissed questions about Moderna’s potential. He describes mRNA as a simple way to develop treatments for scores of ailments. As he told STAT over the summer, “mRNA is like software: You can just turn the crank and get a lot of products going into development.”

Related: SOFTWARE OF LIFE™ IS A MODERNA TRADE MARK FOR MRNA. LITERALLY. AND THEY MAKE APPS

It seems clear, however, that the software has run into bugs.

Patients with Crigler-Najjar are missing a key liver enzyme needed to break down bilirubin, a yellowish substance that crops up in the body as old red blood cells break down. Without that enzyme, bilirubin proliferates in the blood, leading to jaundice, muscle degeneration, and even brain damage.

In Moderna’s eyes, the one-in-million disease looked like an ideal candidate for mRNA therapy. The company crafted a string of mRNA that would encode for the missing enzyme, believing it had hit upon an excellent starting point to prove technology could be used to treat rare diseases.

But things gradually came apart last year.

Every drug has what’s called a therapeutic window, the scientific sweet spot where a treatment is powerful enough to have an effect on a disease but not so strong as to put patients at too much risk. For mRNA, that has proved elusive.

STAT
mRNA jabs are “rewriting the Genetic Code” we call it “information therapy” – Tal Zaks (Ted 2017)

Before COVID-19, the company’s secretive nature, and its failure to deliver a functional product, was drawing comparisons to the infamous biotech startup Theranos. Similar to Moderna, Theranos rarely published any peer-reviewed material. Like Moderna, Theranos mastered the networking game, and recruited high profile individuals to its board in order to vouch for the company’s “revolutionary technologies.” Once valued at well over $10 Billion, Theranos collapsed after it was revealed that the company was running a massive fraud scheme, in addition to its failure to implement its promised blood testing technology.

Jordan Schachtel @JordanSchachtelIn 2015, Dr John Ioannidis published a paper calling attention to Theranos & the shady biotech unicorn industry. Moderna is mentioned as a company that is following the Theranos path of zero disclosures, & publishing zero papers on their “innovative” tech. onlinelibrary.wiley.com/doi/epdf/10.11…
April 15th 2021113 Retweets281 Likes

Moderna’s Mysterious Medicines

FORBES EDITORS’ PICK |Dec 14, 2016

Excerpts:

“Now an obscure lawsuit filed in British Columbia in October sheds light on one of Moderna’s key partners, and through it FORBES can reveal details on Moderna’s amazing but still untested technology.

It appears that the first two products Moderna has entered into clinical trials rely on technology from a small outfit in Vancouver, British Columbia, called Acuitas Therapeutics. (Acuitas is so small, in fact, that its worldwide headquarters are in its CEO’s single-family home.)

Almost all medicines either block proteins–the building blocks of life–or, in the case of expensive biotech drugs, are proteins themselves. But Moderna has been promising to hack an entirely different part of life’s cookbook. In order to turn genetic information encoded in DNA into the cellular machines that actually are proteins, living things use a messenger chemical called mRNA.

Creating these mRNA drugs is a big challenge on many levels. For them to work, Moderna needs to deliver mRNA to the body’s cells. By itself mRNA breaks down in the bloodstream. Tiny Acuitas specializes in one method: lipid-nanoparticle delivery systems. Its technology essentially wraps the mRNA into balls of fat that disguise the drug so that the target cells will readily ingest it.

“Although we are small,” says Thomas Madden, chief executive of Acuitas, “I believe the technology we have developed is highly effective.”

The problem for Madden and Moderna is that Acuitas doesn’t actually own the technology it has licensed to Moderna. The tech belongs to a third company, publicly traded Arbutus, which recently decided to terminate the license for the tech that it had granted to Acuitas. That’s why Acuitas filed the lawsuit in British Columbia, to protect the deal it had. Arbutus immediately countersued, claiming its deal with Acuitas didn’t cover Moderna’s medicines.

The legal mess has its roots in Moderna’s 2011 start, when Robert Langer, an MIT professor, Moderna board member and founder of dozens of biotech companies, told Bancel that Moderna was too underfunded and small to create its own delivery system. So Moderna vetted over a dozen external delivery methods for mRNA and settled on at least three. One belonged to Arbutus, but Moderna turned to tiny Acuitas to get access to it.

Acuitas was formed in 2009 by Madden after a merger eliminated his position at Arbutus’ predecessor, Tekmira Pharmaceuticals. After a contentious lawsuit Madden was able to license from his former employer the novel tech he had helped develop, and Bancel claims Moderna chose to work with Acuitas because it had “the people and the capabilities.”

But that doesn’t explain why Moderna–flush with capital–didn’t make sure that sublicensing through Acuitas would be okay with Arbutus before advancing its new drugs into human studies.

Bancel met with FORBES at a Brooklyn coffee shop on a recent Saturday to dispel the implications of the lawsuit. He is dismissive of Acuitas’ technology. “We knew it was not very good,” he says. “It was just okay.”

He further explains that Moderna is in the process of producing its own nanoparticle lipids. One such lipid, N1GEL (called “Nigel” internally), appears to cause less inflammation than Acuitas’ version. Another is being licensed from Merck. Bancel says Moderna has stopped using the Acuitas tech for new drugs.

That still leaves a somewhat messy situation for any Moderna vaccines that are being developed using Acuitas’ tech.

Data from one vaccine is expected early next year. If results are good, it could lead to a sizzling-hot initial public offering, even if the Canadian lawsuit ultimately affords Arbutus bigger royalty payments from Moderna.”

Well, the two tiny Canadian companies mentioned above bring royalties to the Canada’s treasury (should I say The British Crown?), so don’t expect Trudeau to backpedal too soon

AND IF ONLY THEY HUSSLED WITH PRIVATE FUNDS, AS THEY CLAIMED…

Moderna chief keep claiming that they started to use public funds only as a patch on infrastructure, science and funding they’ve built for years.

Wrong!

It’s known that NIH + NIAID have long been one of their main sources for the “lavish funding” mentioned earlier and when they locked in the government support, they actually started to leverage it and attract even more private funds, in an self-feeding loop that created today’s monster-bubble.

Very few people know they even got money from BARDA and DARPA. As in “military funds”.

Remember this lie from earlier?
“The company has been funded over the years by billions of dollars of private investment,” Zaks told the Freakonomics podcast in August. “Those billions created the opportunity for the U.S. government to come in earlier this year and say, ‘I’m going to add some money to the pot to make sure that you get the development for this vaccine right.'”
Watch this claim getting nuked:

Taken from:

This grid above looks familiar to you? It does to me, but it’s not blood from people who underwent Covid genetic therapies, just something similar. Taken from:

KEI asks DOD to investigate failure to disclose DARPA funding in Moderna patents

  by  Knowledge Ecology International (KEI)

Luis Gil Abinader has taken a deep dive into Moderna’s surprising practice of never declaring government funding in its 126 patents and 154 patent applications, despite having had funding from multiple federal agencies.

One outcome of his research is a 25 page report (RN-2020-3) on Moderna’s failure to report funding from DARPA, and a request by KEI to DOD and DARPA to remedy this, including by taking title to patents where disclosures should have been made. (Text of letter below, and PDF version here).

KEI will also send a letter to BARDA. The letter below was addressed to DOD and DARPA, and focuses on their funding.

Context

The obligation to disclose federal funding in patent applications has been subject to presidential executive orders, statutes, regulations and contracts, including those cited and quoted in Abinader’s report. The disclosure clarifies the public’s rights in the inventions and the obligations on the entity getting the money, on everything from the government’s worldwide royalty free license to the public’s march-in rights, obligations to make inventions available to the public on reasonable terms, and additional safeguards that can be exercised by a government inclined to do so.

Secondly, the disclosure changes the narrative about who has financed the inventive activity, often the most risky part of development.

One of the earlier norms on this was Franklin Roosevelt’s Executive Order 9424, on the Establishment of a Register of Government interests in patents.

In 2018, the regulations on disclosure were modified by NIST (see 83 FR 15954), where, among other things, the government gave itself unlimited time to remedy a failure to disclose federal funding, to eliminate one loophole that created an incentive ignore the disclosure requirement.

In the past, the US Department of Defense has taken title to patents where federal funding was not disclosed. See: Campbell Plastics v. Brownlee, 389 F.3d 1243 (Fed. Cir. 2004).

There is more on the broader issue of disclosure of government funding in patents here: https://www.keionline.org/bayh-dole/failure-to-disclose

The research on the Moderna/DARPA funding is outlined in a 25 page August 27, 2020 report by Luis Gil Abinader, titled: “Moderna failures to disclose DARPA funding in patented inventions.” RN-2020-3

Below is the text of the KEI letter to Dr. Mark T. Esper, Secretary of Defense, and Dr. Amy Jenkins, of the Pandemic Prevention Platform for the Defense Advanced Research Projects Agency (DARPA), regarding the apparent failure by Moderna to disclose DARPA funding in patent applications.
PDF copy here:

2020. September 18. DARPA letter to KEI confirming investigation of Moderna for failure to report government funding in patent applications. https://www.keionline.org/33970

2020. September 4. BARDA is investigating Moderna’s failures to disclose BARDA funding in patent applications. https://www.keionline.org/33907

2020. September 2. KEI request to BARDA concerning Moderna obligations to disclose federal funding in patent applications. https://www.keionline.org/33892

2020. August 30. DARPA announces investigation into Moderna’s apparent failures to disclose mRNA vaccine patents. https://www.keionline.org/33832

2020. August 28. KEI asks DOD to investigate failure to disclose DARPA funding in Moderna patents. https://www.keionline.org/33763

2020. August 27. 2020:3 KEI Research Note: Moderna failures to disclose DARPA funding in patented inventions. https://www.keionline.org/rn-2020-3

2020. August 5. BARDA Responds to KEI, Public Citizen Letter Asking BARDA to Enforce Moderna Contract. https://www.keionline.org/33633

2020. August 4. KEI and Public Citizen request BARDA to address Moderna’s noncompliance with COVID-19 vaccine contract term. https://www.keionline.org/33618

2020. July 1. KEI receives seven new contracts for COVID 19 research from BARDA and DOD, including five using “Other Transactions Authority” that weaken or eliminate Bayh-Dole and FAR Safeguards. https://www.keionline.org/covid19-ota-contracts

2020. May 21. Moderna and US Government Funding of its COVID-19 Vaccine Candidate. https://www.keionline.org/33150

MORE Press Coverage

Washington Post
2020. August 28. “Moderna failed to disclose federal support in vaccine patents, researchers say: The company with a leading coronavirus vaccine candidate did not adhere to a law designed to protect public investment.” Washington Post. Christopher Rowland.
https://www.washingtonpost.com/business/2020/08/28/moderna-vaccine-patents-darpa-funding/

Bloomberg
2020. August 29. “Moderna’s Patents Probed by U.S. Defense Department, FT Says.” Bloomberg. Chiara Vasarri. https://www.bloomberg.com/news/articles/2020-08-29/u-s-government-s-darpa-probes-patents-filed-by-moderna-ft

Axios
2020. August 5. “Moderna skirts disclosures of coronavirus vaccine costs.” Axios. Bob Herman. https://www.axios.com/moderna-barda-coronavirus-funding-disclosure-2775a517-a775-485a-a509-b6906c8535a9.html

STAT
2020. September 4. “A second U.S. agency will review if Moderna disclosed federal funding in vaccine patents.” STAT. Ed Silverman. https://www.statnews.com/pharmalot/2020/09/04/moderna-vaccine-darpa-barda-patents-covid19/

2020. August 8. “Moderna failed to disclose federal funding for vaccine patent applications, advocates say.” STAT. Ed Silverman. https://www.statnews.com/pharmalot/2020/08/28/moderna-covid19-vaccine-coronavirus-patents-darpa/

2020. August 4. “BARDA faces pressure to force Moderna to disclose cost details from its Covid-19 contract.” Ed Silverman. https://www.statnews.com/pharmalot/2020/08/04/covid19-coronavirus-pandemic-barda-moderna-vaccine-transparency/

Financial Times
2020. August 29. “US government’s Darpa probes Moderna’s vaccine patents: Researchers accuse biotech company of failing to disclose federal grants in patents which also cover Covid-19 candidate.” Financial Times. Donato Paolo Mancini. https://www.ft.com/content/2be1f87e-9e96-4e23-9cc5-33ba35e50586

National Public Radio (NPR)
2020. August 4. “Prices For COVID-19 Vaccines Are Starting To Come Into Focus.” NPR. Sydney Lupkin. https://www.statnews.com/pharmalot/2020/08/04/covid19-coronavirus-pandemic-barda-moderna-vaccine-transparency/

Health Policy Watch
2020. September 3. “US Biomedical Advanced Research & Development Agency Reviews Moderna’s US Patents For Alleged Failure To Disclose Federal Funding.” Health Policy Watch. Grace Ren.
https://healthpolicy-watch.news/pharma-watchdog-requests-further-inquiries-into-modernas-us-patents/

2020. September 1. “US Department Of Defense Is Investigating Moderna’s Patents For Allegedly Failing To Disclose Federal Support.” Health Policy Watch. Grace Ren. https://healthpolicy-watch.news/usagency-investigating-moderna-for-allegedly/

The Pharma Letter
2020. September 4. “Non-profit says Moderna hid federal funding from patent office.” The Pharma Letter. https://www.thepharmaletter.com/article/nonprofit-says-moderna-hid-federal-funding-from-patent-office

Life Sciences Intellectual Property Review
2020. September 8. “Moderna’s COVID-19 and Zika patent applications to be investigated.” Life Sciences Intellectual Property Review. Muireann Bolger. https://www.lifesciencesipreview.com/news/moderna-s-covid-19-and-zika-patent-applications-to-be-investigated-4183

Law360
2020. September 4. “HHS Unit Probes Funding For Moderna’s Patented Vaccines.” Law360. Kevin Stawicki. https://www.law360.com/articles/1307690/hhs-unit-probes-funding-for-moderna-s-patented-vaccines

2020. August 31. “DOD Investigating Moderna’s Vaccine Patents.” Law360. Kevin Stawicki. https://www.law360.com/compliance/articles/1305849/dod-investigating-moderna-s-vaccine-patents

2020. August 28. “Activists Say Moderna Hid Gov’t Support For Vaccine Patents.” Law360. Kevin Stawicki. https://www.law360.com/articles/1305474

Moderna’s vaccine was developed with support from the NIAID, and, as covered in a past fact check, analysis from Axios found that the National Institutes of Health, of which the NIAID is part, may own intellectual property used in producing Moderna’s vaccine. Dr. Francis Collins, director of NIH, has also said that NIH has a stake in intellectual property used in the vaccine, though what exactly this means in practical terms is unclear. 

The Dispatch Fact-check

Also…

All the documents Glenn Beck is creaming about and more can be found below:

Nipah virus as in…?

READ: URGENT! DEBUNKING THE NEXT ENGINEERED PANDEMIC: HEMORRHAGIC FEVER (NIPAH, MARBURG, EBOLA)

Well, yeah, no coincidence here either, more proof to that below.

SO WE HAVE A FINACIER WHO TOOK OVER A WELL FUNDED PHARMA START-UP AND BROUGHT IN HUGE FUNDS, IGNITING THE MOTHER OF ALL ENRONS. WHO’S THIS GUY?!

Buckle up, friends, this so far was jus the prelude.

Bancel came to Moderna from the French Merieux Institute.

Merieux happens to be the French billionaire who helped China build the infamous P4 Lab in Wuhan.

Merieux also happens to be an old friend of Xi’s.

That Xi visit at the Merieux HQ in France happened in 2014, not long after this:

Obama & Xi working together on a pandemic playbook in 2012

And then, in 2018..

2017

Bancel maintained a top role in the Merieux Foundation long after leaving the BioMerieux division for Moderna.

CA Merieux Foundation

Therefore no surprise that Moderna was allegedly the first to get the SARS-COV2 genetic code and start working on the mRNA injection.

CONFIDENTIAL DOCUMENTS: MODERNA SENT A MRNA CORONAVIRUS VACCINE CANDIDATE TO UNIVERSITIES WEEKS BEFORE EMERGENCE OF COVID-19

MORE COINCIDENCE THEORIES

In 2017, Moncef Slaoui, the brain behind GSK, also took a seat on the board of Moderna,

Trump awarded Moderna almost $0.5Billion from public money a few days before nominating Slaoui as Warp Speed co-chief. in May 2020.

Trump’s Moroccan “vaccine czar”: worked for Bill Gates, Google, GSK. Worked in China. Transhumanist. Lockdown fanatic

“Valera’s efforts (Moderna subsidiary) have resulted in the demonstration of preclinical efficacy of Moderna’s mRNA-based vaccines in multiple viral disease models, Moderna said.

In the partnership with the Gates Foundation, Valera will apply its mRNA vaccine platform as well as Moderna’s drug platform Messenger RNA Therapeutics™. Designed to produces human proteins, antibodies, and entirely novel protein constructs inside patient cells, the therapeutics are secreted or active intracellularly.” – Genetic Engineering & Biotechnology News

To avoid a conflict of interest, Slaoui resigned from the board of the Massachusetts-based biotech firm Moderna, which had been developing a vaccine for the coronavirus.
He stepped down but he didn’t give up his stakes in Moderna, as the Daily Beast reports:

“Slaoui’s ownership of 156,000 Moderna stock options, disclosed in required federal financial filings, sparked concerns about a conflict of interest.
Democratic Massachusetts Senator Elizabeth Warren called Slaoui out over the matter on Twitter: “It is a huge conflict of interest for the White House’s new vaccine czar to own $10 million of stock in a company receiving government funding to develop a COVID-19 vaccine. Dr. Slaoui should divest immediately.”
The company’s shares skyrocketed last month after news broke of the $483 million in federal funding to work on a coronavirus vaccine.
Slaoui could not immediately be reached for comment on the matter.”

Slaoui also sits on the boards of SutroVax, the Biotechnology Innovation Organization, the International AIDS Vaccine Initiative, and the PhRMA Foundation

Gates, Fauci and Slaoui have long been making and selling scandalous vaccines together. It’s a cartel

So we should add Bancel to this cover graphic
DAVOS 2022: BANCEL AND FAUCI MEET AGAIN TO WHINE ABOUT THE ANNOYANCE WE ARE TO THEM. MORE TO COME, SCUMBAGS!

LAST MINUTE:

The circle has just closed.
Unless China faked another interview to prop up another myth.

So this has never been about health, just a global scale racketeering operation that’s coming to light about about to go bust. You can speed up this process simply by spreading this expose far and wide!

UPDATE MARCH 21, 2022: VOILA!

Via our ex-BlackRock friend Edward Dowd. I rest my case, but I bet they will “unrest” it soon.

To be continued?
Our work and existence, as media and people, is funded solely by our most generous readers and we want to keep this way.
Help SILVIEW.media survive and grow, please donate here, anything helps. Thank you!

! Articles can always be subject of later editing as a way of perfecting them

ORDER

That Wikipedia screenshot that started to make rounds of the Internet now – it’s fake. But I have something better. “Much much better”!

OFFICIAL WHITE HOUSE WEBSITE ARCHIVE LINK

Almost everything you need to know about Klaus Schwab’s Youth:

KLAUS SCHWAB’S YOUTH IS CALLED “YOUNG GLOBAL LEADERS”, READY FOR REGIME CHANGE IN UNALIGNED COUNTRIES

Ivanka Trump being a Young Global Leader at Davos 2020
Dr. Oz aka Dr. Why

WAIT, IT GETS EVEN DEEPER, BELIEVE IT OR NOT!

Trumpies stuck forks in their own eyes to avoid seeing this and I don’t speak to leftoids, so it went largely overlooked in 2020, but I think it aged smoothly. Don’t perpetuate that grave error, see:

LOOK WHO’S SPEAKING CHINESE! HOW DEEP IS THE STING?

If this makes your head spin, I have some bad news: much more where these came from – The Internet!

To be continued?
Our work and existence, as media and people, is funded solely by our most generous readers and we want to keep this way.
Help SILVIEW.media survive and grow, please donate here, anything helps. Thank you!

! Articles can always be subject of later editing as a way of perfecting them

Only days ago, Luc Montagnier was up in arms on the barricades against Covidiocracy. Suddenly, he is told to have left the battlefield, in peace, not as a fallen general.
Why such a sudden ‘change of heart’?
This is the question.

Got around doing a little video summary, but the devil is in the details below.

“At the age of 89 (August 18, 1932 – February 8, 2022), Professor Luc Montagnier died at the American Hospital in Neuilly-sur-Seine. Doctor Gérard Guillaume, one of his most faithful collaborators, tells us that he left in peace, surrounded by his children.

He was a biologist and virologist, but also and above all a man of remarkable intelligence, who lived for science. In addition to having been named Nobel Prize for Medicine in 2008 for the discovery of the AIDS virus, he worked alongside the greatest scientific institutes in the world during his life. Emeritus research director at the CNRS, professor at the Institut Pasteur, director of the Center for Molecular and Cellular Biology at Queens College of the City University of New York, director of a research institute at the Jiao-tong University of Shanghai. He supported the Academy of Sciences as well as the National Academy of Medicine through his research for many years. For this, he has received countless awards and accolades.

Despite his advanced age and despite all the criticism he suffered in the autumn of his life, notably from part of the scientific community, Luc Montagnier has always fought for free science. We were lucky enough to be able to welcome him several times at FranceSoir, and would like to give him all the honors that are due to him.” – France Soir

He’s just earned his wings

The official announcements say he died in peace, “surrounded by his youngsters”.

Many call this death ‘sudden’, as in “unforeseen”.

Others. such as myself, have been wondering for long why is he still allowed to roam free and blow the whistle, given his deep involvement with the AIDS scam, his out-spoken anti-Pharmafia stance and, more recently, his total dissidence to the Covid / vaccine narrative.

Rare video from World Health Summit, 2010

“His death took place on Tuesday 8 February, on the same day as the funeral of the Italian biologist Franco Trinca struck down by a very violent and suspicious form of Covid-19 despite being in excellent health and used to take care of himself with a thousand precautions. Trinca had often taken up the complaints of the internationally renowned French scientist who, having worked in the field of vaccines, had denounced the dangers of gene serums based on messenger RNA above all for the risk of creating degenerative brain diseases from prions, as highlighted in our latest investigation.” – VT

OMG OMG!
SOURCE

NO CAUSE OF DEATH PROVIDED



Information surrounding his death are inexistent yet, I’m writing this less than 12h after the official announcement. I will add here anything relevant to it, as much as to why he was a major threat to Pharmafia and the WEF cartel.

UPDATE: Associated Press and thus the global mainstream media finally caught up but still no additional info, just more character assassination rituals.

LAST TIMES HE APPEARED IN PUBLIC:

Four weeks before Montagnier’s death:

“On January 9, Montagnier once again appeared on an international media, the Wall Street Journal, in an editorial titled Omicron makes Biden’s vaccination obligations obsolete, co-signed by American constitutionalist Jed Rubenfeld who another disgraced celebrity: married to Amy Chua, fellow law professor at Yale and author of the world bestseller on the mother tiger, Rubenfeld accused of sexual assaults on female students and suspended by Yale for two years. After the article on the Wsj and before the intervention in Milan, Luc Montagnier appeared last Wednesday in the Luxembourg House of Parliament to support a petition against compulsory vaccination, but his commitment against vaccines began well before the Covid era.” – Italy24 News

So, on January 12, 2022, he concluded his career gloriously participating in THIS INVESTIGATION ON CHILDHOOD COVID VACCINATION BY THE LUXEMBOURG PARLIAMENT

And then…

Three weeks before Montagnier’s death:

January 15th, 2022, at a protest in Milan, Italy:

He seems in pretty good shape to me.

“Luc Montagnier, who in 2009 suggested fighting AIDS with better nutrition, he is experiencing an unexpected return these days, accompanied as always by the American assistant and companion Suzanne McDonnell Long, who was next to him in Milan when he added that it was a crime to give this vaccine to children. As in the past, when Montagnier sold expensive papaya preparations in pharmacies, the problem that the professor does not provide any proof of what he claims. His sentences are not based on any research he has done in recent months or years, but respect for the scientific community is not something that would interest him or his followers.” – Italy24 News

So he almost literally died on the barricades…

Last time I checked…

New evidence, including sworn affidavits from leading experts such as Professor Luc A. Montagnier, has been submitted to the International Criminal Court by lawyers in several countries alleging Government’s across the world and their advisors are complicit in genocide, crimes against humanity and breaches of the Nuremberg Code.Daily Expose

“Attorney Melinda C. Mayne, and Kaira S. McCallum submitted a 27-page ‘Request for Investigation’ to the International Criminal Court (ICC) at The Hague back in April 2021 alleging the UK Government and its advisors were complicit in crimes against humanity in the name of Covid-19.

On the 28th of April 2021, the pair received a formal acknowledgement from the ICC and were assigned a case number – ‘141/21’. Since then the pair have been gathering new evidence to use in their ICC claim and have established connections with lawyers and research scientists from around the world.

A new press release released on the 17th August, which can be viewed here, confirms that the pair have received sworn affidavits from leading experts including research scientist and nuclear cardiologist Dr Richard M. Fleming, the Nobel Laureate virologist Professor Luc  A. Montagnier, and Dr Kevin W. McCairn, a neuroscientist and expert on neurological disease.

Professor Luc A Montagnier, who won a Nobel prize for his work on the HIV virus, claimed in April 2020 that he believed the novel coronavirus was created in a laboratory. Then in May 2021 the expert virologist stated that “Mass vaccinations are a scientific error as well as a medical error. It is an unacceptable mistake. The history books will show that, because it is the vaccination that is creating the variants”.

A new claim has also been submitted to the ICC due to the vast amount of new evidence and information that has come to light in the past few months, and the lawyers say they now have compelling evidence that “the SARS-CoV-2 virus and the Covid-19 ‘vaccines’ are deliberately engineered bioweapons that have been released in two phashes on unsuspecting peoples of the world”.

Attorney Melinda C. Mayne, and Kaira S. McCallum have also confirmed that they have now be joined by lawyers who have filed similar Requests for Investigation to the International Criminal Court, in France, the Czech Republic and Slovakia.

Because of this a letter was sent to the ICC on the 12th August 2021 requesting they all be allowed to submit a joint claim, whilst also submitting preliminary evidence for the allegations common to everyone across the world, and requesting the right to have claims specific to individual countries also investigated by the ICC.” – Daily Expose

They called him a “conspirationist” because he was an early adept of the Chinese lab origin of the virus

KARy MULLIS, THE PCR INVENTOR, DIED JUST A FEW MONTHS BEFORE COVID.
DID MONTAIGNER, THE HIV DISCOVERER, DIE JUST MONTHS BEFORE A BIG AIDS RESURGENCE?

Seven weeks before Montagnier’s death:

Four days before Montagnier’s death:

You’ve seen the increasing media coverage about a new HIV strain, I suppose.

Instead of AIDS, I’d call that, and I’m not the only one, “Vaccine-Induced Auto-Immune Syndrome”, but let’s pretend we go along with the official narrative.

Logically, Montaigner should’ve been the first to summon with the Bat Signal.

That never happened. His death happened.

The day Montagnier died:

This was aired in US on the day Montagnier died.

I think we need a recap. we’ll start here and I will gradually build a picture, come back later:

WUHAN-GATES – 3. “COVID-19 Created in Lab with HIV”. Medicine Nobel confirms Indian Research disclosed by Gospa News

(My excerpts, full story HERE)

Professor Luc Montagnier, Nobel Prize for Medicine 2008, to the microphones of the French podcast, specialized in medicine and health, “Pourquoi Docteur” has torn the veil of silence, has broken the sepulcher of taboos, accrediting the research of the Kusuma School of Biology of New Delhi, withdrawn by the authors but republished worldwide by me on Gospa News and Veterans Today a few days ago and immediately targeted by the skepticism of improvised scientists.

Indian research sensationally withdrawn but recovered by Gospa News

«With my colleague, the biomathematician Jean-Claude Perez, we have carefully analyzed the description of the genome of this Rna virus. We weren’t the first, a group of Indian researchers tried to publish a study showing that the complete genome of this virus that has within the sequences of another virus: that of AIDS. The Indian team retracted after publication. But scientific truth always emerges. The AIDS sequence was inserted into the coronavirus genome to attempt to make the vaccine» said Montagnier.

Luc Montagnier, the French virologist Nobel Prize winner for Medicine in 2008 for his AIDS research

In 7 lines, one of the world’s leading experts in medicine makes “tabula rasa” of somewhat sibylline hypotheses so far promoted by virologists, perhaps even induced by some housekeeper worried about national security in the face of the confirmation of a pandemic capable of causing 120 thousand deaths.

His words carry enormous weight: because in 2008 Montagnier discovered the human immunodeficiency virus HIV as the cause of the AIDS epidemic so much that he won the Nobel Prize for Medicine together with Françoise Barré-Sinoussi and Harald zur Hausen.

«Coronavirus would be a manipulated virus, accidentally released from a Chinese laboratory in Wuhan where the AIDS vaccine was being studied. Professor Luc Montagnier said so» writes the Italian Journalism Agency (AGI), one of the few big media to report the news with prominence.

However, it publishes it with less evidence compared to another article on the statements of the American immunologist Anthony Fauci, director of the American National Institute of Allergy and Infectious Diseases, who persistenly supported the natural origin of the virus.

As we have shown in 12 detailed reports on bio-weapon theory, the United States of America are among the prime suspects, together with China, for this pandemic catastrophe.

It is therefore understandable that the American doctor tries to divert attention from the hypothesis of a pathogen manipulated by bioengineering since the most disturbing experiment was conducted by the biosafety 3 of the Burnett Womack Biohazard center at the Chapell Hill site of the University of North Carolina together with the biosafety laboratory 4 of the Wuhan Institute of Virology.

Not only. The research had been supported by the institute where Fauci works through «grants from the National Institute of Allergy & Infectious Disease and the National Institute of Aging of the United States National Institutes of Health (NIH), the National Natural Science Foundation of China and the USAID-EPT-PREDICT funding from EcoHealth Alliance» as stated in the Abstract published by Nature Medicine published in report no. 9.

The trial led to «building a chimeric CoV with a bat CoV S gene (SHC014) in the backbone of a SARS CoV that has adapted to infect mice (MA15) and is capable of infecting human cells».

Researchers Shan-Lu Liu, Linda J. Saif, Susan R. Weiss and Lishan Su wrote that in a study of February 28, in which, however, they showed some fundamental divergences, equal to 96% for about 5 thousand nucleotides, between that “chimeric” CoronaVirus, that is, created in the laboratory and not existing in nature, and the current real pathogen of the SARS-Cov-2 pandemic, so called from the English acronym of Acute Respiratory Severe Syndrome.

But in the supervirus study conducted primarily in the Chapel Hill laboratories of the University of North Carolina, mention that was also made experiments «similar to those using an HIV-based pseudovirus, prepared as previously described and tested on HeLa cells (Wuhan Institute of Virology) which the ACE2 orthologists expressed».

Despite the difference between Covid-19 and the chimeric supervirus, nothing prevents us from thinking that this “prototype” it was then further modified in one of the US Pentagon’s 25 military laboratories, where highly top-secret projects are also managed directly by the Central Intelligence Agency or in one of the 11 existing in the US territory only (on which we will write shortly), including the National Biodefense Analysis and Countermeasures Center – NBACC of the USAMRIID (US Army Medical Institute of Infectious Diseases) in Fort Detrick, Maryland, closed last July for a mysterious biosecurity loss ever better detailed.

http://www.gospanews.net/en/2020/03/24/coronavirus-bioweapon-7-top-secret-military-missions-in-ukraine-fort-detrick-sigonella-wuhan-and-modena/embed/#?secret=YswmTKBpeG

Or that that highly lethal “chimeric supervirus”, such as Covid-19’s “L” genotype, may have been further processed in the Wuhan Virology Institute itself, around which there have been numerous suspicious deaths (of which we will write shortly), concealed by the proverbial Chinese military secrecy imposed by the risk of a capital punishment for espionage or terrorism.

The BSL 4 biosafety labs of the Wuhan Institute of Virology in China

Montagnier is a famous virologist, he was an illustrious professor and researcher of the Pasteur Institute in Paris (one of the first to elaborate a research on the first CoronaVirus strain of SARS in 2003) but for some years he has been working in the most important research center in Shanghai, the Jiao Tong University.

Therefore he is by no means extraneous to matters connected with China and certainly knows Wuhan’s laboratory strongly desired by the entourage of former president Jiang Zemin, historic leader of the Chinese Communist Party who has become popular in the world for international trials for human rights violations in Tibet and for the nickname “executioner of Tiananmen”.

Now Montagnier not only confirms the validity of the Indian study on the traces of HIV inside Covid-19, reported by me in the essential passages from Gospa News and Veterans Today, but supports the “less serious” hypothesis, namely that of an accidental release of the genetically manipulated virus.

Porquoi Docteur’s scoop with the interview with Montagnier

«The hypothesis is that this virus leaves the Wuhan laboratory. It is a high security laboratory but despite all the virus has escaped from the control of the promoters. The history of the fish market is a beautiful legend but it is not possible that it is only a virus transmitted by a bat, it is probably from this that they started, then they modified it. Maybe they wanted to make an AIDS vaccine using a coronavirus as an antigen carrier. A work of sorcerer’s apprentices can be said. Because we must not forget that we are in the world of nature, there are balances to be respected» said Montagnier peremptorily.

According to the scientist, the altered elements of this virus will however be eliminated as it spreads: «Nature does not accept any molecular manipulation, it will eliminate these unnatural changes and even if nothing is done, things will improve, but unfortunately after many deaths».

Also read: AIDS AND COVID ARE TWO COMMERCIAL BRANDS AND ONE BUSINESS MODEL BY FAUCI

To be continued?
Our work and existence, as media and people, is funded solely by our most generous readers and we want to keep this way.
Help SILVIEW.media survive and grow, please donate here, anything helps. Thank you!

! Articles can always be subject of later editing as a way of perfecting them

Just a quick heads up as many people hurry to cry “victory!” after recent announcements from UK, France, Czech Republic and even Israel.
I can’t fully be with you due to personal issues, but I don’t want to let you fall in another trap and later disappointment either.

https://www.reuters.com/world/europe/france-unveil-timetable-easing-covid-restrictions-2022-01-20/

Israel: “Finance minister calls for end to Green Pass”

https://www.timesofisrael.com/as-serious-covid-cases-near-500-finance-minister-calls-for-end-to-green-pass/

But…

  • Global leaders have been looking at what 2022 might hold for the COVID-19 pandemic at The Davos Agenda.
  • Speakers addressed questions around vaccine equity, the impact on society and economics and whether it might become endemic.
  • Below are some of the key talking points.

SOURCE: WEF

We’re heading towards the third year of the COVID-19 pandemic, which has disrupted lives and livelihoods across the planet and led to at least 5.5 million deaths around the world.

As the Omicron COVID-19 variant surges in many countries – and indeed saw the deferral of an in-person meeting in Davos – the pandemic has been front of mind for many at The Davos Agenda.

So, where is the virus headed? Here’s what speakers from different sectors have said so far this week.

Tackling the COVID-19 pandemic

Xi Jinping, President of the People’s Republic of China, opened this week by reminding us of the work that’s already been done.

“The international community has fought a tenacious battle,” he said.

The global vaccination drive has played a major role in the progress we’ve made so far, with Richard Hatchett, the CEO of CEPI, reminding us of the work of COVAX.

The vaccine-sharing facility, which CEPI co-leads alongside Gavi and the World Health Organization, delivered its one billionth dose of COVID-19 vaccines over the weekend.

The pandemic has impacted every aspect of our lives, though, Israeli Prime Minister Naftali Bennett reminded us – and that has driven the response in his country.

Endemic or pandemic?

The history of infectious diseases can tell us something about the next stages of the pandemic, Anthony Fauci, the Director of the US National Institute of Allergy and Infectious Diseases, explained.

Endemicity would mean ‘a non-disruptive presence without elimination’, he said. Similar to other cold-weather upper respiratory infections or parainfluenzas, he explained.

We’re not going to eliminate this virus, he said.

FAUCI @ WEF’S DAVOS 2022 (starts 6 min in)

Richard Hatchett said his long-term view is that we should anticipate COVID-19 will behave more like flu.

“It will continue to circulate, it will be around, people will get sick and there will be continual evolution of the virus.”

Mike Ryan, the Executive Director of the WHO’s Health Emergencies Programme, struck a cautionary tone though in the Meeting the Challenge of Vaccine Equity session.

“We won’t end the virus this year,” he said. “We may never end the virus. Pandemic viruses end up becoming part of the ecosystem. What we can end is the public health emergency.”

And, in terms of endemic versus pandemic, he was clear. “Endemic does not mean good,” he said, citing the examples of endemic malaria or endemic HIV which kill 100,000s of people. “Endemic just means it’s here forever.”

“What we need to do is get to low-levels of disease incidence, with maximum vaccination of our populations, so nobody has to die.” That’s the end of the emergency, that’s the end of the pandemic, he concluded.

….

And Svein Tore Holsether, President and Chief Executive Officer, Yara International ASA, told us that a move from shareholder to stakeholder capitalism isn’t just needed, it’s expected, he said.

And, sustainability and environmental concerns will remain paramount – particularly in light of COP26.

Our lifestyles and our throwaway culture have exacerbated the climate challenge, Indian Prime Minister Narendra Modi said on Monday. It’s essential we move towards a circular economy, he explained.?

The next steps

The path is unlikely to be smooth though. Beyond the health challenges discussed above – vaccine equity, for example – hurdles need to be overcome in areas from trust to reform in global systems.

Sharan Burrow, General Secretary of the International Trade Union Confederation, explained more about the issue of trust.

And she wasn’t alone. Speakers at the announcement of the Schwab Foundation for Social Entrepreneurship’s Social Innovators of the Year 2022 award were also clear on the issue of trust.

The global community needs to work together, even more than it has already, speakers from across sessions agreed. This is particularly important to ensure the equitable distribution of vaccines, explained President Xi Jinping.

And reform is needed, whether of global financial systems, or the means by which we can equitably produce and distribute vaccines.

And there it goes… Climate-19 in full swing, as I predicted almost 2 years ago

https://news.yahoo.com/german-leader-champions-tack-climate-135118725.html

Also have you seen this below? Well, consider their hopes for vaccination rates have bee crushed by our resistance, hence the delay and later desperation.

VACCINES MAY ACTUALLY END THE PANDEMIC BY JULY, BUT NOT AS YOU THINK

To be updated, most probably.

To be continued?
Our work and existence, as media and people, is funded solely by our most generous readers and we want to keep this way.
Help SILVIEW.media survive and grow, please donate here, anything helps. Thank you!

! Articles can always be subject of later editing as a way of perfecting them

ORDER

It’s here, it’s solid, it’s backed by tons more science.
I’m just making sure you see this and I have it archived, without feeling I need to add my comments.

Evidence for a connection between coronavirus disease-19 and exposure to radiofrequency radiation from wireless communications including 5G

Beverly Rubik 1 , 2 , * and Robert R. Brown 3
Author information

Journal of Clinical and Translational Research. 2021 Oct 26; 7(5): 666–681.

Abstract

Background and Aim:

Coronavirus disease (COVID-19) public health policy has focused on the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus and its effects on human health while environmental factors have been largely ignored. In considering the epidemiological triad (agent-host-environment) applicable to all disease, we investigated a possible environmental factor in the COVID-19 pandemic: ambient radiofrequency radiation from wireless communication systems including microwaves and millimeter waves. SARS-CoV-2, the virus that caused the COVID-19 pandemic, surfaced in Wuhan, China shortly after the implementation of city-wide (fifth generation [5G] of wireless communications radiation [WCR]), and rapidly spread globally, initially demonstrating a statistical correlation to international communities with recently established 5G networks. In this study, we examined the peer-reviewed scientific literature on the detrimental bioeffects of WCR and identified several mechanisms by which WCR may have contributed to the COVID-19 pandemic as a toxic environmental cofactor. By crossing boundaries between the disciplines of biophysics and pathophysiology, we present evidence that WCR may: (1) cause morphologic changes in erythrocytes including echinocyte and rouleaux formation that can contribute to hypercoagulation; (2) impair microcirculation and reduce erythrocyte and hemoglobin levels exacerbating hypoxia; (3) amplify immune system dysfunction, including immunosuppression, autoimmunity, and hyperinflammation; (4) increase cellular oxidative stress and the production of free radicals resulting in vascular injury and organ damage; (5) increase intracellular Ca2+ essential for viral entry, replication, and release, in addition to promoting pro-inflammatory pathways; and (6) worsen heart arrhythmias and cardiac disorders.

Relevance for Patients:

In short, WCR has become a ubiquitous environmental stressor that we propose may have contributed to adverse health outcomes of patients infected with SARS-CoV-2 and increased the severity of the COVID-19 pandemic. Therefore, we recommend that all people, particularly those suffering from SARS-CoV-2 infection, reduce their exposure to WCR as much as reasonably achievable until further research better clarifies the systemic health effects associated with chronic WCR exposure.

1. Introduction

1.1. Background

Coronavirus disease 2019 (COVID-19) has been the focus of international public health policy since 2020. Despite unprecedented public health protocols to quell the pandemic, the number of COVID-19 cases continues to rise. We propose a reassessment of our public health strategies.

According to the Center for Disease Control and Prevention (CDC), the simplest model of disease causation is the epidemiological triad consisting of three interactive factors: the agent (pathogen), the environment, and the health status of the host [1]. Extensive research is being done on the agent, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Risk factors that make a host more likely to succumb to the disease have been elucidated. However, environmental factors have not been sufficiently explored. In this paper, we investigated the role of wireless communication radiation (WCR), a widespread environmental stressor.

We explore the scientific evidence suggesting a possible relationship between COVID-19 and radiofrequency radiation related to wireless communications technology including fifth generation (5G) of wireless communications technology, henceforth referred to as WCR. WCR has already been recognized as a form of environmental pollution and physiological stressor [2]. Assessing the potentially detrimental health effects of WCR may be crucial to develop an effective, rational public health policy that may help expedite eradication of the COVID-19 pandemic. In addition, because we are on the verge of worldwide 5G deployment, it is critical to consider the possible damaging health effects of WCR before the public is potentially harmed.

5G is a protocol that will use high frequency bands and extensive bandwidths of the electromagnetic spectrum in the vast radiofrequency range from 600 MHz to nearly 100 GHz, which includes millimeter waves (>20 GHz), in addition to the currently used third generation (3G) and fourth generation (4G) long-term evolution (LTE) microwave bands. 5G frequency spectrum allocations differ from country to country. Focused pulsed beams of radiation will emit from new base stations and phased array antennas placed close to buildings whenever persons access the 5G network. Because these high frequencies are strongly absorbed by the atmosphere and especially during rain, a transmitter’s range is limited to 300 meters. Therefore, 5G requires base stations and antennas to be much more closely spaced than previous generations. Plus, satellites in space will emit 5G bands globally to create a wireless worldwide web. The new system therefore requires significant densification of 4G infrastructure as well as new 5G antennas that may dramatically increase the population’s WCR exposure both inside structures and outdoors. Approximately 100,000 emitting satellites are planned to be launched into orbit. This infrastructure will significantly alter the world’s electromagnetic environment to unprecedented levels and may cause unknown consequences to the entire biosphere, including humans. The new infrastructure will service the new 5G devices, including 5G mobile phones, routers, computers, tablets, self-driving vehicles, machine-to-machine communications, and the Internet of Things.

The global industry standard for 5G is set by the 3G Partnership Project (3GPP), which is an umbrella term for several organizations developing standard protocols for mobile telecommunications. The 5G standard specifies all key aspects of the technology, including frequency spectrum allocation, beam-forming, beam steering, multiplexing multiple in, multiple out schemes, as well as modulation schemes, among others. 5G will utilize from 64 to 256 antennas at short distances to serve virtually simultaneously a large number of devices within a cell. The latest finalized 5G standard, Release 16, is codified in the 3GPP published Technical Report TR 21.916 and may be downloaded from the 3GPP server at https://www.3gpp.org/specifications. Engineers claim that 5G will offer performance up to 10 times that of current 4G networks [3].

COVID-19 began in Wuhan, China in December 2019, shortly after city-wide 5G had “gone live,” that is, become an operational system, on October 31, 2019. COVID-19 outbreaks soon followed in other areas where 5G had also been at least partially implemented, including South Korea, Northern Italy, New York City, Seattle, and Southern California. In May 2020, Mordachev [4] reported a statistically significant correlation between the intensity of radiofrequency radiation and the mortality from SARS-CoV-2 in 31 countries throughout the world. During the first pandemic wave in the United States, COVID-19 attributed cases and deaths were statistically higher in states and major cities with 5G infrastructure as compared with states and cities that did not yet have this technology [5].

There is a large body of peer reviewed literature, since before World War II, on the biological effects of WCR that impact many aspects of our health. In examining this literature, we found intersections between the pathophysiology of SARS-CoV-2 and detrimental bioeffects of WCR exposure. Here, we present the evidence suggesting that WCR has been a possible contributing factor exacerbating COVID-19.

1.2. Overview on COVID-19

The clinical presentation of COVID-19 has proven to be highly variable, with a wide range of symptoms and variability from case to case. According to the CDC, early disease symptoms may include sore throat, headache, fever, cough, chills, among others. More severe symptoms including shortness of breath, high fever, and severe fatigue may occur in a later stage. The neurological sequela of taste and smell loss has also been described.

Ing et al. [6] determined 80% of those affected have mild symptoms or none, but older populations and those with comorbidities, such as hypertension, diabetes, and obesity, have a greater risk for severe disease [7]. Acute respiratory distress syndrome (ARDS) can rapidly occur [8] and cause severe shortness of breath as endothelial cells lining blood vessels and epithelial cells lining airways lose their integrity, and protein rich fluid leaks into adjacent air sacs. COVID-19 can cause insufficient oxygen levels (hypoxia) that have been seen in up to 80% of intensive care unit (ICU) patients [9] exhibiting respiratory distress. Decreased oxygenation and elevated carbon dioxide levels in patients’ blood have been observed, although the etiology for these findings remains unclear.

Massive oxidative damage to the lungs has been observed in areas of airspace opacification documented on chest radiographs and computed tomography (CT) scans in patients with SARS-CoV-2 pneumonia [10]. This cellular stress may indicate a biochemical rather than a viral etiology [11].

Because disseminated virus can attach itself to cells containing an angiotensin-converting enzyme 2 (ACE2) receptor; it can spread and damage organs and soft tissues throughout the body, including the lungs, heart, intestines, kidneys, blood vessels, fat, testes, and ovaries, among others. The disease can increase systemic inflammation and induce a hypercoagulable state. Without anticoagulation, intravascular blood clots can be devastating [12].

In COVID-19 patients referred to as “long-haulers,” symptoms can wax and wane for months [13]. Shortness of breath, fatigue, joint pain, and chest pain can become persistent symptoms. Post-infectious brain fog, cardiac arrhythmia, and new onset hypertension have also been described. Long-term chronic complications of COVID-19 are being defined as epidemiological data are collected over time.

As our understanding of COVID-19 continues to evolve, environmental factors, particularly those of wireless communication electromagnetic fields, remain unexplored variables that may be contributing to the disease including its severity in some patients. Next, we summarize the bioeffects of WCR exposure from the peer reviewed scientific literature published over decades.

1.3. Overview on bioeffects of WCR exposure

Organisms are electrochemical beings. Low-level WCR from devices, including mobile telephony base antennas, wireless network protocols utilized for the local networking of devices and internet access, trademarked as Wi-Fi (officially IEEE 802.11b Direct Sequence protocol; IEEE, Institute of Electrical and Electronic Engineers) by the Wi-Fi alliance, and mobile phones, among others, may disrupt regulation of numerous physiological functions. Non-thermal bioeffects (below the power density that causes tissue heating) from very low-level WCR exposure have been reported in numerous peer-reviewed scientific publications at power densities below the International Commission on Non-Ionizing Radiation Protection (ICNIRP) exposure guidelines [14]. Low-level WCR has been found to impact the organism at all levels of organization, from the molecular to the cellular, physiological, behavioral, and psychological levels. Moreover, it has been shown to cause systemic detrimental health effects including increased cancer risk [15], endocrine changes [16], increased free radical production [17], deoxyribonucleic acid (DNA) damage [18], changes to the reproductive system [19], learning and memory defects [20], and neurological disorders [21]. Having evolved within Earth’s extremely low-level natural radiofrequency background, organisms lack the ability to adapt to heightened levels of unnatural radiation of wireless communications technology with digital modulation that includes short intense pulses (bursts).

The peer-reviewed world scientific literature has documented evidence for detrimental bioeffects from WCR exposure including 5G frequencies over several decades. The Soviet and Eastern European literature from 1960 to 1970s demonstrates significant biological effects, even at exposure levels more than 1000 times below 1 mW/cm2, the current guideline for maximum public exposure in the US. Eastern studies on animal and human subjects were performed at low exposure levels (<1 mW/cm2) for long durations (typically months). Adverse bioeffects from WCR exposure levels below 0.001 mW/cm2 have also been documented in the Western literature. Damage to human sperm viability including DNA fragmentation by internet-connected laptop computers at power densities from 0.0005 to 0.001 mW/cm2 has been reported [22]. Chronic human exposure to 0.000006 – 0.00001 mW/cm2 produced significant changes in human stress hormones following a mobile phone base station installation [23]. Human exposures to cell phone radiation at 0.00001 – 0.00005 mW/cm2 resulted in complaints of headache, neurological problems, sleep problems, and concentration problems, corresponding to “microwave sickness” [24,25]. The effects of WCR on prenatal development in mice placed near an “antenna park” exposed to power densities from 0.000168 to 0.001053 mW/cm2 showed a progressive decrease in the number of newborns and ended in irreversible infertility [26]. Most US research has been performed over short durations of weeks or less. In recent years, there have been few long-term studies on animals or humans.

Illness from WCR exposure has been documented since the early use of radar. Prolonged exposure to microwaves and millimeter waves from radar was associated with various disorders termed “radio-wave sickness” decades ago by Russian scientists. A wide variety of bioeffects from nonthermal power densities of WCR were reported by Soviet research groups since the 1960s. A bibliography of over 3700 references on the reported biological effects in the world scientific literature was published in 1972 (revised 1976) by the US Naval Medical Research Institute [27,28]. Several relevant Russian studies are summarized as follows. Research on Escherichia coli bacteria cultures show power density windows for microwave resonance effects for 51.755 GHz stimulation of bacterial growth, observed at extremely low power densities of 10−13 mW/cm2 [29], illustrating an extremely low level bioeffect. More recently Russian studies confirmed earlier results of Soviet research groups on the effects of 2.45 GHz at 0.5 mW/cm2 on rats (30 days exposure for 7 h/day), demonstrating the formation of antibodies to the brain (autoimmune response) and stress reactions [30]. In a long-term (1 – 4 year) study comparing children who use mobile phones to a control group, functional changes, including greater fatigue, decreased voluntary attention, and weakening of semantic memory, among other adverse psychophysiological changes, were reported [31]. Key Russian research reports that underlie the scientific basis for Soviet and Russian WCR exposure guidelines to protect the public, which are much lower than the US guidelines, have been summarized [32].

By comparison to the exposure levels employed in these studies, we measured the ambient level of WCR from 100 MHz to 8 GHz in downtown San Francisco, California in December, 2020, and found an average power density of 0.0002 mW/cm2. This level is from the superposition of multiple WCR devices. It is approximately 2 × 1010 times above the natural background.

Pulsed radio-frequency radiation such as WCR exhibits substantially different bioeffects, both qualitatively and quantitatively (generally more pronounced) compared to continuous waves at similar time-averaged power densities [3336]. The specific interaction mechanisms are not well understood. All types of wireless communications employ extremely low frequency (ELFs) in the modulation of the radiofrequency carrier signals, typically pulses to increase the capacity of information transmitted. This combination of radiofrequency radiation with ELF modulation(s) is generally more bioactive, as it is surmised that organisms cannot readily adapt to such rapidly changing wave forms [3740]. Therefore, the presence of ELF components of radiofrequency waves from pulsing or other modulations must be considered in studies on the bioeffects of WCR. Unfortunately, the reporting of such modulations has been unreliable, especially in older studies [41].

The BioInitiative Report [42], authored by 29 experts from ten countries, and updated in 2020, provides a scholarly contemporary summary of the literature on the bioeffects and health consequences from WCR exposure, including a compendium of supporting research. Recent reviews have been published [4346]. Two comprehensive reviews on the bioeffects of millimeter waves report that even short-term exposures produce marked bioeffects [47,48].Go to:

2. Methods

An ongoing literature study of the unfolding pathophysiology of SARS-CoV-2 was performed. To investigate a possible connection to bioeffects from WCR exposure, we examined over 250 peer-reviewed research reports from 1969 to 2021, including reviews and studies on cells, animals, and humans. We included the world literature in English and Russian reports translated to English, on radio frequencies from 600 MHz to 90 GHz, the carrier wave spectrum of WCR (2G to 5G inclusive), with particular emphasis on nonthermal, low power densities (<1 mW/cm2), and long-term exposures. The following search terms were used in queries in MEDLINE® and the Defense Technical Information Center (https://discover.dtic.mil) to find relevant study reports: radiofrequency radiation, microwave, millimeter wave, radar, MHz, GHz, blood, red blood cell, erythrocyte, hemoglobin, hemodynamic, oxygen, hypoxia, vascular, inflammation, pro-inflammatory, immune, lymphocyte, T cell, cytokine, intracellular calcium, sympathetic function, arrhythmia, heart, cardiovascular, oxidative stress, glutathione, reactive oxygen species (ROS), COVID-19, virus, and SARS-CoV-2. Occupational studies on WCR exposed workers were included in the study. Our approach is akin to Literature-Related Discovery, in which two concepts that have heretofore not been linked are explored in the literature searches to look for linkage(s) to produce novel, interesting, plausible, and intelligible knowledge, that is, potential discovery [49]. From analysis of these studies in comparison with new information unfolding on the pathophysiology of SARS-CoV-2, we identified several ways in which adverse bioeffects of WCR exposure intersect with COVID-19 manifestations and organized our findings into five categories.Go to:

3. Results

Table 1 lists the manifestations common to COVID-19 including disease progression and the corresponding adverse bioeffects from WCR exposure. Although these effects are delineated into categories — blood changes, oxidative stress, immune system disruption and activation, increased intracellular calcium (Ca2+), and cardiac effects — it must be emphasized that these effects are not independent of each other. For example, blood clotting and inflammation have overlapping mechanisms, and oxidative stress is implicated in erythrocyte morphological changes as well as in hypercoagulation, inflammation, and organ damage.

Table 1

Bioeffects of Wireless Communication Radiation (WCR) exposure in relation to COVID-19 manifestations and their progression

Wireless communications radiation (WCR) exposure bioeffectsCOVID-19 manifestations
Blood changes
 Short-term: rouleaux, echinocytes
 Long-term: reduced blood clotting time, reduced hemoglobin, hemodynamic disorders
Blood changes
 Rouleaux, echinocytes
 Hemoglobin effects; vascular effects
 →Reduced hemoglobin in severe disease; autoimmune hemolytic anemia; hypoxemia and hypoxia
 →Endothelial injury; impaired microcirculation; hypercoagulation; disseminated intravascular coagulopathy (DIC); pulmonary embolism; stroke
Oxidative stress
 Glutathione level decrease; free radicals and lipid peroxide increase; superoxide dismutase activity decrease; oxidative injury in tissues and organs
Oxidative stress
 Glutathione level decrease; free radical increase and damage; apoptosis→Oxidative injury; organ damage in severe disease
Immune system disruption and activation
 Immune suppression in some studies; immune hyperactivation in other studies
 Long-term: suppression of T-lymphocytes; inflammatory biomarkers increased; autoimmunity; organ injury
Immune system disruption and activation
 Decreased production of T-lymphocytes; elevated inflammatory biomarkers.
 →Immune hyperactivation and inflammation; cytokine storm in severe disease; cytokine-induced hypo-perfusion with resulting hypoxia; organ injury; organ failure
Increased intracellular calcium
 From activation of voltage-gated calcium channels on cell membranes, with numerous secondary effects
Increased intracellular calcium
 →Increased virus entry, replication, and release
 →Increased NF-κB, pro-inflammatory processes, coagulation, and thrombosis
Cardiac effects
 Up-regulation of sympathetic nervous system; palpitations and arrhythmias
Cardiac effects
 Arrhythmias
 →Myocarditis; myocardial ischemia; cardiac injury; cardiac failure

Open in a separate window

Supportive evidence including study details and citations are provided in the text under each subject heading, i.e., blood changes, oxidative stress, etc.

3.1. Blood changes

WCR exposure can cause morphologic changes in blood readily seen through phase contrast or dark-field microscopy of live peripheral blood samples. In 2013, Havas observed erythrocyte aggregation including rouleaux (rolls of stacked red blood cells) in live peripheral blood samples following 10 min human exposure to a 2.4 GHz cordless phone [50]. Although not peer reviewed, one of us (Rubik) investigated the effect of 4G LTE mobile phone radiation on the peripheral blood of ten human subjects, each of whom had been exposed to cell phone radiation for two consecutive 45-min intervals [51]. Two types of effects were observed: increased stickiness and clumping of red blood cells with rouleaux formation, and subsequent formation of echinocytes (spiky red blood cells). Red blood cell clumping and aggregation are known to be actively involved in blood clotting [52]. The prevalence of this phenomenon on exposure to WCR in the human population has not yet been determined. Larger controlled studies should be performed to further investigate this phenomenon.

Similar red blood cell changes have been described in peripheral blood of COVID-19 patients [53]. Rouleaux formation has been observed in 1/3 of COVID-19 patients, whereas spherocytes and echinocyte formation is more variable. Spike protein engagement with ACE2 receptors on cells lining the blood vessels can lead to endothelial damage, even when isolated [54]. Rouleaux formation, particularly in the setting of underlying endothelial damage, can clog the microcirculation, impeding oxygen transport, contributing to hypoxia, and increasing the risk of thrombosis [52]. Thrombogenesis associated with SARS-CoV-2 infection may also be caused by direct viral binding to ACE2 receptors on platelets [55].

Additional blood effects have been observed in both humans and animals exposed to WCR. In 1977, a Russian study reported that rodents irradiated with 5 – 8 mm waves (60 – 37 GHz) at 1 mW/cm2 for 15 min/day over 60 days developed hemodynamic disorders, suppressed red blood cell formation, reduced hemoglobin, and an inhibition of oxygen utilization (oxidative phosphorylation by the mitochondria) [56]. In 1978, a 3-year Russian study on 72 engineers exposed to millimeter wave generators emitting at 1 mW/cm2 or less showed a decrease in their hemoglobin levels and red blood cell counts, and a tendency toward hypercoagulation, whereas a control group showed no changes [57]. Such deleterious hematologic effects from WCR exposure may also contribute to the development of hypoxia and blood clotting observed in COVID-19 patients.

It has been proposed that the SARS-CoV-2 virus attacks erythrocytes and causes degradation of hemoglobin [11]. Viral proteins may attack the 1-beta chain of hemoglobin and capture the porphyrin, along with other proteins from the virus catalyzing the dissociation of iron from heme [58]. In principle this would reduce the number of functional erythrocytes and cause the release of free iron ions that could cause oxidative stress, tissue damage, and hypoxia. With hemoglobin partially destroyed and lung tissue damaged by inflammation, patients would be less able to exchange carbon dioxide (CO2) and oxygen (O2), and would become oxygen depleted. In fact, some COVID-19 patients show reduced hemoglobin levels, measuring 7.1 g/L and even as low as 5.9 g/L in severe cases [59]. Clinical studies of almost 100 patients from Wuhan revealed that the hemoglobin levels in the blood of most patients infected with SARS-CoV-2 are significantly lowered resulting in compromised delivery of oxygen to tissues and organs [60]. In a meta-analysis of four studies with a total of 1210 patients and 224 with severe disease, hemoglobin values were reduced in COVID-19 patients with severe disease compared to those with milder forms [59]. In another study on 601 COVID-19 patients, 14.7% of anemic COVID-19 ICU patients and 9% of non-ICU COVID-19 patients had autoimmune hemolytic anemia [61]. In patients with severe COVID-19 disease, decreased hemoglobin along with elevated erythrocyte sedimentation rate (ESR), C-reactive protein, lactate dehydrogenase, albumin [62], serum ferritin [63], and low oxygen saturation [64] provide additional support for this hypothesis. In addition, packed red blood cell transfusion may promote recovery of COVID-19 patients with acute respiratory failure [65].

In short, both WCR exposure and COVID-19 may cause deleterious effects on red blood cells and reduced hemoglobin levels contributing to hypoxia in COVID-19. Endothelial injury may further contribute to hypoxia and many of the vascular complications seen in COVID-19 [66] that are discussed in the next section.

3.2. Oxidative stress

Oxidative stress is a non-specific pathological condition reflecting an imbalance between an increased production of ROS and an inability of the organism to detoxify the ROS or to repair the damage they cause to biomolecules and tissues [67]. Oxidative stress can disrupt cell signaling, cause the formation of stress proteins, and generate highly reactive free radicals, which can cause DNA and cell membrane damage.

SARS-CoV-2 inhibits intrinsic pathways designed to reduce ROS levels, thereby increasing morbidity. Immune dysregulation, that is, the upregulation of interleukin (IL)-6 and tumor necrosis factor α (TNF-α) [68] and suppression of interferon (IFN) α and IFN β [69] have been identified in the cytokine storm accompanying severe COVID-19 infections and generates oxidative stress [10]. Oxidative stress and mitochondrial dysfunction may further perpetuate the cytokine storm, worsening tissue damage, and increasing the risk of severe illness and death.

Similarly low-level WCR generates ROS in cells that cause oxidative damage. In fact, oxidative stress is considered to be one of the primary mechanisms in which WCR exposure causes cellular damage. Among 100 currently available peer-reviewed studies investigating oxidative effects of low-intensity WCR, 93 of these studies confirmed that WCR induces oxidative effects in biological systems [17]. WCR is an oxidative agent with a high pathogenic potential especially when exposure is continuous [70].

Oxidative stress is also an accepted mechanism causing endothelial damage [71]. This may manifest in patients with severe COVID-19 in addition to increasing the risk for blood clot formation and worsening hypoxemia [10]. Low levels of glutathione, the master antioxidant, have been observed in a small group of COVID-19 patients, with the lowest level found in the most severe cases [72]. The finding of low glutathione levels in these patients further supports oxidative stress as a component of this disease [72]. In fact, glutathione, the major source of sulfhydryl-based antioxidant activity in the human body, may be pivotal in COVID-19 [73]. Glutathione deficiency has been proposed as the most likely cause of serious manifestations in COVID-19 [72]. The most common co-morbidities, hypertension [74]; obesity [75]; diabetes [76]; and chronic obstructive pulmonary disease [74] support the concept that pre-existing conditions causing low levels of glutathione may work synergistically to create the “perfect storm” for both the respiratory and vascular complications of severe infection. Another paper citing two cases of COVID-19 pneumonia treated successfully with intravenous glutathione also supports this hypothesis [77].

Many studies report oxidative stress in humans exposed to WCR. Peraica et al. [78] found diminished blood levels of glutathione in workers exposed to WCR from radar equipment (0.01 mW/cm2 – 10 mW/cm2; 1.5 – 10.9 GHz). Garaj-Vrhovac et al. [79] studied bioeffects following exposure to non-thermal pulsed microwaves from marine radar (3 GHz, 5.5 GHz, and 9.4 GHz) and reported reduced glutathione levels and increased malondialdehyde (marker for oxidative stress) in an occupationally exposed group [79]. Blood plasma of individuals residing near mobile phone base stations showed significantly reduced glutathione, catalase, and superoxide dismutase levels over unexposed controls [80]. In a study on human exposure to WCR from mobile phones, increased blood levels of lipid peroxide were reported, while enzymatic activities of superoxide dismutase and glutathione peroxidase in the red blood cells decreased, indicating oxidative stress [81].

In a study on rats exposed to 2450 MHz (wireless router frequency), oxidative stress was implicated in causing red blood cell lysis (hemolysis) [82]. In another study, rats exposed to 945 MHz (base station frequency) at 0.367 mW/cm2 for 7 h/day, over 8 days, demonstrated low glutathione levels and increased malondialdehyde and superoxide dismutase enzyme activity, hallmarks for oxidative stress [83]. In a long-term controlled study on rats exposed to 900 MHz (mobile phone frequency) at 0.0782 mW/cm2 for 2 h/day for 10 months, there was a significant increase in malondialdehyde and total oxidant status over controls [84]. In another long-term controlled study on rats exposed to two mobile phone frequencies, 1800 MHz and 2100 MHz, at power densities 0.04 – 0.127 mW/cm2 for 2 h/day over 7 months, significant alterations in oxidant-antioxidant parameters, DNA strand breaks, and oxidative DNA damage were found [85].

There is a correlation between oxidative stress and thrombogenesis [86]. ROS can cause endothelial dysfunction and cellular damage. The endothelial lining of the vascular system contains ACE2 receptors that are targeted by SARS-CoV-2. The resulting endotheliitis can cause luminal narrowing and result in diminished blood flow to downstream structures. Thrombi in arterial structures can further obstruct blood flow causing ischemia and/or infarcts in involved organs, including pulmonary emboli and strokes. Abnormal blood coagulation leading to micro-emboli was a recognized complication early in the history of COVID-19 [87]. Out of 184 ICU COVID-19 patients, 31% showed thrombotic complications [88]. Cardiovascular clotting events are a common cause of COVID-19 deaths [12]. Pulmonary embolism, disseminated intravascular coagulation (DIC), liver, cardiac, and renal failure have all been observed in COVID-19 patients [89].

Patients with the highest cardiovascular risk factors in COVID-19 includ males, the elderly, diabetics, and obese and hypertensive patients. However, increased incidence of strokes in younger patients with COVID-19 has also been described [90].

Oxidative stress is caused by WCR exposure and is known to be implicated in cardiovascular disease. Ubiquitous environmental exposure to WCR may contribute to cardiovascular disease by creating a chronic state of oxidative stress [91]. This would lead to oxidative damage to cellular constituents and alter signal transduction pathways. In addition, pulse-modulated WCR can cause oxidative injury in liver, lung, testis, and heart tissues mediated by lipid peroxidation, increased levels of nitric oxides, and suppression of the antioxidant defense mechanism [92].

In summary, oxidative stress is a major component in the pathophysiology of COVID-19 as well as in cellular damage caused by WCR exposure.

3.3. Immune system disruption and activation

When SARS-CoV-2 first infects the human body, it attacks cells lining the nose, throat, and upper airway harboring ACE2 receptors. Once the virus gains access to a host cell through one of its spike proteins, which are the multiple protuberances projecting from the viral envelope that bind to ACE2 receptors, it converts the cell into a virus self-replicating entity.

In response to COVID-19 infection, both an immediate systemic innate immune response as well as a delayed adaptive response has been shown to occur [93]. The virus can also cause a dysregulation of the immune response, particularly in the decreased production of T-lymphocytes. [94]. Severe cases tend to have lower lymphocyte counts, higher leukocyte counts and neutrophil-lymphocyte ratios, as well as lower percentages of monocytes, eosinophils, and basophils [94]. Severe cases of COVID-19 show the greatest impairment in T-lymphocytes.

In comparison, low-level WCR studies on laboratory animals also show impaired immune function [95]. Findings include physical alterations in immune cells, a degradation of immunological responses, inflammation, and tissue damage. Baranski [96] exposed guinea pigs and rabbits to continuous or pulse-modulated 3000 MHz microwaves at an average power density of 3.5 mW/cm2 for 3 h/day over 3 months and found nonthermal changes in lymphocyte counts, abnormalities in nuclear structure, and mitosis in the erythroblastic cell series in the bone marrow and in lymphoid cells in lymph nodes and spleen. Other investigators have shown diminished T-lymphocytes or suppressed immune function in animals exposed to WCR. Rabbits exposed to 2.1 GHz at 5mW/cm2 for 3 h/day, 6 days/week, for 3 months, showed suppression of T-lymphocytes [97]. Rats exposed to 2.45 GHz and 9.7 GHz for 2 h/day, 7 days/week, for 21 months showed a significant decrease in the levels of lymphocytes and an increase in mortality at 25 months in the irradiated group [98]. Lymphocytes harvested from rabbits irradiated with 2.45 GHz for 23 h/day for 6 months show a significant suppression in immune response to a mitogen [99].

In 2009, Johansson conducted a literature review, which included the 2007 Bioinitiative Report. He concluded that electromagnetic fields (EMF) exposure, including WCR, can disturb the immune system and cause allergic and inflammatory responses at exposure levels significantly less than current national and international safety limits and raise the risk for systemic disease [100]. A review conducted by Szmigielski in 2013 concluded that weak RF/microwave fields, such as those emitted by mobile phones, can affect various immune functions both in vitro and in vivo [101]. Although the effects are historically somewhat inconsistent, most research studies document alterations in the number and activity of immune cells from RF exposure. In general, short-term exposure to weak microwave radiation may temporarily stimulate an innate or adaptive immune response, but prolonged irradiation inhibits those same functions.

In the acute phase of COVID-19 infection, blood tests demonstrate elevated ESR, C-reactive protein, and other elevated inflammatory markers [102], typical of an innate immune response. Rapid viral replication can cause death of epithelial and endothelial cells and result in leaky blood vessels and pro-inflammatory cytokine release [103]. Cytokines, proteins, peptides, and proteoglycans that modulate the body’s immune response, are modestly elevated in patients with mild-to-moderate disease severity [104]. In those with severe disease, an uncontrolled release of pro-inflammatory cytokines–a cytokine storm–can occur. Cytokine storms originate from an imbalance in T-cell activation with dysregulated release of IL-6, IL-17, and other cytokines. Programmed cell death (apoptosis), ARDS, DIC, and multi-organ system failure can all result from a cytokine storm and increase the risk of mortality.

By comparison, Soviet researchers found in the 1970s that radiofrequency radiation can damage the immune system of animals. Shandala [105] exposed rats to 0.5 mW/cm2 microwaves for 1 month, 7 h/day, and found impaired immune competence and induction of autoimmune disease. Rats irradiated with 2.45 GHz at 0.5 mW/cm2 for 7 h daily for 30 days produced autoimmune reactions, and 0.1 – 0.5 mW/cm2 produced persistent pathological immune reactions [106]. Exposure to microwave radiation, even at low levels (0.1 – 0.5 mW/cm2), can impair immune function, causing physical alterations in the essential cells of the immune system and a degradation of immunologic responses [107]. Szabo et al. [108] examined the effects of 61.2 GHz exposure on epidermal keratinocytes and found an increase in IL-1b, a pro-inflammatory cytokine. Makar et al. [109] found that immunosuppressed mice irradiated 30 min/day for 3 days by 42.2 GHz showed increased levels of TNF-α, a cytokine produced by macrophages.

In short, COVID-19 can lead to immune dysregulation as well as cytokine storms. By comparison, exposure to low-level WCR as observed in animal studies can also compromise the immune system, with chronic daily exposure producing immunosuppression or immune dysregulation including hyperactivation.

3.4. Increased intracellular calcium

In 1992, Walleczek first suggested that ELF electromagnetic fields (<3000 Hz) may be affecting membrane-mediated Ca2+ signaling and lead to increased intracellular Ca2+ [110]. The mechanism of irregular gating of voltage-gated ion channels in cell membranes by polarized and coherent, oscillating electric or magnetic fields was first presented in 2000 and 2002 [40,111]. Pall [112] in his review of WCR-induced bioeffects combined with use of calcium channel blockers (CCB) noted that voltage-gated calcium channels play a major role in WCR bioeffects. Increased intracellular Ca+2 results from the activation of voltage-gated calcium channels, and this may be one of the primary mechanisms of action of WCR on organisms.

Intracellular Ca2+ is essential for virus entry, replication, and release. It has been reported that some viruses can manipulate voltage-gated calcium channels to increase intracellular Ca2+ thereby facilitating viral entry and replication [113]. Research has shown that the interaction between a virus and voltage-gated calcium channels promote virus entry at the virus-host cell fusion step [113]. Thus, after the virus binds to its receptor on a host cell and enters the cell through endocytosis, the virus takes over the host cell to manufacture its components. Certain viral proteins then manipulate calcium channels, thereby increasing intracellular Ca2+, which facilitates further viral replication.

Even though direct evidence has not been reported, there is indirect evidence that increased intracellular Ca2+ may be involved in COVID-19. In a recent study, elderly hospitalized COVID-19 patients treated with CCBs, amlodipine or nifedipine, were more likely to survive and less likely to require intubation or mechanical ventilation than controls [114]. Furthermore, CCBs strongly limit SARS-CoV-2 entry and infection in cultured epithelial lung cells [115]. CCBs also block the increase of intracellular Ca2+ caused by WCR exposure as well as exposure to other electromagnetic fields [112].

Intracellular Ca2+ is a ubiquitous second messenger relaying signals received by cell surface receptors to effector proteins involved in numerous biochemical processes. Increased intracellular Ca2+ is a significant factor in upregulation of transcription nuclear factor KB (NF-κB) [116], an important regulator of pro-inflammatory cytokine production as well as coagulation and thrombotic cascades. NF-κB is hypothesized to be a key factor underlying severe clinical manifestations of COVID-19 [117].

In short, WCR exposure, therefore, may enhance the infectivity of the virus by increasing intracellular Ca2+ that may also indirectly contribute to inflammatory processes and thrombosis.

3.5. Cardiac effects

Cardiac arrhythmias are more commonly encountered in critically ill patients with COVID-19 [118]. The cause for arrhythmia in COVID-19 patients is multifactorial and includes cardiac and extra-cardiac processes [119]. Direct infection of the heart muscle by SARS-CoV-19 causing myocarditis, myocardial ischemia caused by a variety of etiologies, and heart strain secondary to pulmonary or systemic hypertension can result in cardiac arrhythmia. Hypoxemia caused by diffuse pneumonia, ARDS, or extensive pulmonary emboli represent extra-cardiac causes of arrhythmia. Electrolyte imbalances, intravascular fluid imbalance, and side effects from pharmacologic regimens can also result in arrhythmias in COVID-19 patients. Patients admitted to ICUs have been shown to have a higher increase in cardiac arrhythmias, 16.5% in one study [120]. Although no correlation between EMFs and arrhythmia in COVID-19 patients has been described in the literature, many ICUs are equipped with wireless patient monitoring equipment and communication devices producing a wide range of EMF pollution [121].

COVID-19 patients commonly show increased levels of cardiac troponin, indicating damage to the heart muscle [122]. Cardiac damage has been associated with arrhythmias and increased mortality. Cardiac injury is thought to be more often secondary to pulmonary emboli and viral sepsis, but direct infection of the heart, that is, myocarditis, can occur through direct viral binding to ACE2 receptors on cardiac pericytes, affecting local, and regional cardiac blood flow [60].

Immune system activation along with alterations in the immune system may result in atherosclerotic plaque instability and vulnerability, that is, presenting an increased risk for thrombus formation, and contributing to development of acute coronary events and cardiovascular disease in COVID-19.

Regarding WCR exposure bioeffects, in 1969 Christopher Dodge of the Biosciences Division, U.S. Naval Observatory in Washington DC, reviewed 54 papers and reported that radiofrequency radiation can adversely affect all major systems of the body, including impeding blood circulation; altering blood pressure and heart rate; affecting electrocardiograph readings; and causing chest pain and heart palpitations [123]. In the 1970s Glaser reviewed more than 2000 publications on radiofrequency radiation exposure bioeffects and concluded that microwave radiation can alter the electrocardiogram, cause chest pain, hypercoagulation, thrombosis, and hypertension in addition to myocardial infarction [27,28]. Seizures, convulsions, and alteration of the autonomic nervous system response (increased sympathetic stress response) have also been observed.

Since then, many other researchers have concluded that WCR exposure can affect the cardiovascular system. Although the nature of the primary response to millimeter waves and consequent events are poorly understood, a possible role for receptor structures and neural pathways in the development of continuous millimeter wave-induced arrhythmia has been proposed [47]. In 1997, a review reported that some investigators discovered cardiovascular changes including arrhythmias in humans from long-term low-level exposure to WCR including microwaves [124]. However, the literature also shows some unconfirmed findings as well as some contradictory findings [125]. Havas et al. [126] reported that human subjects in a controlled, double-blinded study were hyper-reactive when exposed to 2.45 GHz, digitally pulsed (100 Hz) microwave radiation, developing either an arrhythmia or tachycardia and upregulation of the sympathetic nervous system, which is associated with the stress response. Saili et al. [127] found that exposure to Wi-Fi (2.45 GHz pulsed at 10 Hz) affects heart rhythm, blood pressure, and the efficacy of catecholamines on the cardiovascular system, indicating that WCR can act directly and/or indirectly on the cardiovascular system. Most recently, Bandara and Weller [91] present evidence that people who live near radar installations (millimeter waves: 5G frequencies) have a greater risk of developing cancer and experiencing heart attacks. Similarly, those occupationally exposed have a greater risk of coronary heart disease. Microwave radiation affects the heart, and some people are more vulnerable if they have an underlying heart abnormality [128]. More recent research suggests that millimeter waves may act directly on the pacemaker cells of the sinoatrial node of the heart to change the beat frequency, which may underlie arrhythmias and other cardiac issues [47].

In short, both COVID-19 and WCR exposure can affect the heart and cardiovascular system, directly and/or indirectly.Go to:

4. Discussion

Epidemiologists, including those at the CDC, consider multiple causal factors when evaluating the virulence of an agent and understanding its ability to spread and cause disease. Most importantly, these variables include environmental cofactors and the health status of the host. Evidence from the literature summarized here suggests a possible connection between several adverse health effects of WCR exposure and the clinical course of COVID-19 in that WCR may have worsened the COVID-19 pandemic by weakening the host and exacerbating COVID-19 disease. However, none of the observations discussed here prove this linkage. Specifically, the evidence does not confirm causation. Clearly COVID-19 occurs in regions with little wireless communication. Furthermore, the relative morbidity caused by WCR exposure in COVID-19 is unknown.

We recognize that many factors have influenced the pandemic’s course. Before restrictions were imposed, travel patterns facilitated the seeding of the virus, causing early rapid global spread. Population density, higher mean population age, and socioeconomic factors certainly influenced early viral spread. Air pollution, especially particulate matter PM2.5 (2.5 micro-particulates), likely increased symptoms in patients with COVID-19 lung disease [129].

We postulate that WCR possibly contributed to the early spread and severity of COVID-19. Once an agent becomes established in a community, its virulence increases [130]. This premise can be applied to the COVID-19 pandemic. We surmise that “hot spots” of the disease that initially spread around the world were perhaps seeded by air travel, which in some areas were associated with 5G implementation. However, once the disease became established in those communities, it was able to spread more easily to neighboring regions where populations were less exposed to WCR. Second and third waves of the pandemic disseminated widely throughout communities with and without WCR, as might be expected.

The COVID-19 pandemic has offered us an opportunity to delve further into the potential adverse effects of WCR exposure on human health. Human exposure to ambient WCR significantly increased in 2020 as a “side effect” to the pandemic. Stay-at-home measures designed to reduce the spread of COVID-19 inadvertently resulted in greater public exposure to WCR, as people conducted more business and school related activities through wireless communications. Telemedicine created another source of WCR exposure. Even hospital inpatients, particular ICU patients, experienced increased WCR exposure as new monitoring devices utilized wireless communication systems that may exacerbate health disorders. It would potentially provide valuable information to measure ambient WCR power densities in home and work environments when comparing disease severity in patient populations with similar risk factors.

The question of causation could be investigated in future studies. For example, a clinical study could be conducted in COVID-19 patient populations with similar risk factors, to measure the WCR daily dose in COVID-19 patients and look for a correlation with disease severity and progression over time. As wireless device carrier frequencies and modulations may differ, and the power densities of WCR fluctuate constantly at a given location, this study would require patients to wear personal microwave dosimeters (monitoring badges). In addition, controlled laboratory studies could be conducted on animals, for example, humanized mice infected with SARS-CoV-2, in which groups of animals exposed to minimal WCR (control group) as well as medium and high power densities of WCR could be compared for disease severity and progression.

A major strength of this paper is that the evidence rests on a large body of scientific literature reported by many scientists worldwide and over several decades–experimental evidence of adverse bioeffects of WCR exposure at nonthermal levels on humans, animals, and cells. The Bioinitiative Report [42], updated in 2020, summarizes hundreds of peer-reviewed scientific papers documenting evidence of nonthermal effects from exposures ≤1 mW/cm2. Even so, some laboratory studies on the adverse health effects of WCR have sometimes utilized power densities exceeding 1mW/cm2. In this paper, almost all of the studies that we reviewed included experimental data at power densities ≤1 mW/cm2.

A potential criticism of this paper is that adverse bioeffects from nonthermal exposures are not yet universally accepted in science. Moreover, they are not yet considered in establishing public health policy in many nations. Decades ago, Russians and Eastern Europeans compiled considerable data on nonthermal bioeffects, and subsequently set guidelines at lower radiofrequency radiation exposure limits than the US and Canada, that is, below levels where nonthermal effects are observed. However, the Federal Communications Commission (FCC, a US government entity) and ICNIRP guidelines operate on thermal limits based on outdated data from decades ago, allowing the public to be exposed to considerably higher radiofrequency radiation power densities. Regarding 5G, the telecommunication industry claims that it is safe because it complies with current radiofrequency radiation exposure guidelines of the FCC and ICNIRP. These guidelines were established in 1996 [131], are antiquated, and are not safety standards. Thus, there are no universally accepted safety standards for wireless communication radiation exposure. Recently international bodies, such as the EMF Working Group of the European Academy of Environmental Medicine, have proposed much lower guidelines, taking into account nonthermal bioeffects from WCR exposure in multiple sources [132].

Another weakness of this paper is that some of the bioeffects from WCR exposure are inconsistently reported in the literature. Replicated studies are often not true replications. Small differences in method, including unreported details, such as prior history of exposure of the organisms, non-uniform body exposure, and other variables can lead to inadvertent inconsistency. Moreover, not surprisingly, industry-sponsored studies tend to show less adverse bioeffects than studies conducted by independent researchers, suggesting industry bias [133]. Some experimental studies that are not industry-sponsored have also shown no evidence of harmful effects of WCR exposure. It is noteworthy, however, that studies employing real-life WCR exposures from commercially available devices have shown high consistency in revealing adverse effects [134].

WCR bioeffects depend on specific values of wave parameters including frequency, power density, polarization, exposure duration, modulation characteristics, as well as the cumulative history of exposure and background levels of electromagnetic, electric and magnetic fields. In laboratory studies, bioeffects observed also depend on genetic parameters and physiological parameters such as oxygen concentration [135]. The reproducibility of bioeffects of WCR exposure has sometimes been difficult due to failure to report and/or control all of these parameters. Similar to ionizing radiation, the bioeffects of WCR exposure can be subdivided into deterministic, that is, dose-dependent effects and stochastic effects that are seemingly random. Importantly, WCR bioeffects can also involve “response windows” of specific parameters whereby extremely low-level fields can have disproportionally detrimental effects [136]. This nonlinearity of WCR bioeffects can result in biphasic responses such as immune suppression from one range of parameters, and immune hyperactivation from another range of parameters, leading to variations that may appear inconsistent.

In gathering reports and examining existing data for this paper, we looked for outcomes providing evidence to support a proposed connection between the bioeffects of WCR exposure and COVID-19. We did not make an attempt to weigh the evidence. The radiofrequency radiation exposure literature is extensive and currently contains over 30,000 research reports dating back several decades. Inconsistencies in nomenclature, reporting of details, and cataloging of keywords make it difficult to navigate this enormous literature.

Another shortcoming of this paper is that we do not have access to experimental data on 5G exposures. In fact, little is known about population exposure from real-world WCR, which includes exposure to WCR infrastructure and the plethora of WCR emitting devices. In relation to this, it is difficult to accurately quantify the average power density at a given location, which varies greatly, depending on the time, specific location, time-averaging interval, frequency, and modulation scheme. For a specific municipality it depends on the antenna density, which network protocols are used, as, for example, 2G, 3G, 4G, 5G, Wi-Fi, WiMAX (Worldwide Interoperability for Microwave Access), DECT (Digitally Enhanced Cordless Telecommunications), and RADAR (Radio Detection and Ranging). There is also WCR from ubiquitous radio wave transmitters, including antennas, base stations, smart meters, mobile phones, routers, satellites, and other wireless devices currently in use. All of these signals superimpose to yield the total average power density at a given location that typically fluctuates greatly over time. No experimental studies on adverse health effects or safety issues of 5G have been reported, and none are currently planned by the industry, although this is sorely needed.

Finally, there is an inherent complexity to WCR that makes it very difficult to fully characterize wireless signals in the real world that may be associated with adverse bioeffects. Real world digital communication signals, even from single wireless devices, have highly variable signals: variable power density, frequency, modulation, phase, and other parameters changing constantly and unpredictably each moment, as associated with the short, rapid pulsations used in digital wireless communication [137]. For example, in using a mobile phone during a typical phone conversation, the intensity of emitted radiation varies significantly each moment depending on signal reception, number of subscribers sharing the frequency band, location within the wireless infrastructure, presence of objects and metallic surfaces, and “speaking” versus “non-speaking” mode, among others. Such variations may reach 100% of the average signal intensity. The carrier radiofrequency constantly changes between different values within the available frequency band. The greater the amount of information (text, speech, internet, video, etc.), the more complex the communication signals become. Therefore, we cannot estimate accurately the values of these signal parameters including ELF components or predict their variability over time. Thus, studies on the bioeffects of WCR in the laboratory can only be representative of real-world exposures [137].

This paper points to the need for further research on nonthermal WCR exposure and its potential role in COVID-19. Moreover, some of the WCR exposure bioeffects that we discuss here — oxidative stress, inflammation, and immune system disruption — are common to many chronic diseases, including autoimmune disease and diabetes. Thus, we hypothesize that WCR exposure may also be a potential contributing factor in many chronic diseases.

When a course of action raises threats of harm to human health, precautionary measures should be taken, even if clear causal relationships are not yet fully established. Therefore, we must apply the Precautionary Principle [138] regarding wireless 5G. The authors urge policymakers to execute an immediate worldwide moratorium on wireless 5G infrastructure until its safety can be assured.

Several unresolved safety issues should be addressed before wireless 5G is further implemented. Questions have been raised about 60 GHz, a key 5G frequency planned for extensive use, which is a resonant frequency of the oxygen molecule [139]. It is possible that adverse bioeffects might ensue from oxygen absorption of 60 GHz. In addition, water shows broad absorption in the GHz spectral region along with resonance peaks, for example, strong absorption at 2.45 GHz that is used in 4G Wi-Fi routers. This raises safety issues about GHz exposure of the biosphere, since organisms are comprised of mostly water, and changes in the structure of water due to GHz absorption have been reported that affect organisms [140]. Bioeffects from prolonged WCR exposure of the whole body need to be investigated in animal and human studies, and long-term exposure guidelines need to be considered. Independent scientists in particular should conduct concerted research to determine the biological effects of real-world exposure to WCR frequencies with digital modulation from the multiplicity of wireless communication devices. Testing could also include real-life exposures to multiple toxins (chemical and biological) [141], because multiple toxins may lead to synergistic effects. Environmental impact assessments are also needed. Once the long-term biological effects of wireless 5G are understood, we can set clear safety standards of public exposure limits and design an appropriate strategy for safe deployment.Go to:

5. Conclusion

There is a substantial overlap in pathobiology between COVID-19 and WCR exposure. The evidence presented here indicates that mechanisms involved in the clinical progression of COVID-19 could also be generated, according to experimental data, by WCR exposure. Therefore, we propose a link between adverse bioeffects of WCR exposure from wireless devices and COVID-19.

Specifically, evidence presented here supports a premise that WCR and, in particular, 5G, which involves densification of 4G, may have exacerbated the COVID-19 pandemic by weakening host immunity and increasing SARS-CoV-2 virulence by (1) causing morphologic changes in erythrocytes including echinocyte and rouleaux formation that may be contributing to hypercoagulation; (2) impairing microcirculation and reducing erythrocyte and hemoglobin levels exacerbating hypoxia; (3) amplifying immune dysfunction, including immunosuppression, autoimmunity, and hyperinflammation; (4) increasing cellular oxidative stress and the production of free radicals exacerbating vascular injury and organ damage; (5) increasing intracellular Ca2+ essential for viral entry, replication, and release, in addition to promoting pro-inflammatory pathways; and (6) worsening heart arrhythmias and cardiac disorders.

WCR exposure is a widespread, yet often neglected, environmental stressor that can produce a wide range of adverse bioeffects. For decades, independent research scientists worldwide have emphasized the health risks and cumulative damage caused by WCR [42,45]. The evidence presented here is consistent with a large body of established research. Healthcare workers and policymakers should consider WCR a potentially toxic environmental stressor. Methods for reducing WCR exposure should be provided to all patients and the general population.

Acknowledgments

The authors acknowledge small contributions to early versions of this paper by Magda Havas and Lyn Patrick. We are grateful to Susan Clarke for helpful discussions and suggested edits of early drafts of the manuscript.

Conflict of Interest

The authors declare that they have no conflicts of interest in preparing and publishing this manuscript. No competing financial interests exist.

To be continued?
Our work and existence, as media and people, is funded solely by our most generous readers and we want to keep this way.
Help SILVIEW.media survive and grow, please donate here, anything helps. Thank you!

! Articles can always be subject of later editing as a way of perfecting them

Sometimes my memes are 3D. And you can own them. Or send them to someone.
You can even eat some of them.
CLICK HERE

His voters will deeply regret not doing their own research.
Here are 7+1 reasons why:

#0

“I have pondered for years, how they [Carlyle Group] achieved this unbelievable performance during their private equity years. Part of the answer had to be in Carlyle’s connections. Over the years, they hired former Secretary of Defense Frank Carlucci, George HW Bush, James Baker, John Major (former British Prime Minister) and numerous others. “

Bedford Bulletin

Carlyle Empire

  by Eric Leser
  Le Monde –  April 29, 2004

The biggest private investor in the world, deeply entrenched in the weapons’ sector, is a discreet group that cultivates dealings with influential men, including Bush father and son.

  One year ago, May 1, 2003, George Bush, strapped up in a fighter pilot’s suit, landed on the deck of the aircraft carrier USS Abraham-Lincoln along the coast of California. The image became famous. Under a banner proclaiming “Mission Accomplished”, the president prematurely announced the end of military operations in Iraq and his victory. Back on dry land the next day, he made another martial speech, not far from San Diego, in a United Defense Industries’ weapons factory.

  This company is one of the Pentagon’s main suppliers. It manufactures, among other things, missiles, transport vehicles, and the light Bradley armored vehicle. Its main shareholder is the biggest private investor in the world, a discreet group, called Carlyle.

  It’s not listed on the stock market and doesn’t have to show its accounts to any but its 550 investors- billionaires or pension funds. Carlyle manages eighteen billion dollars today, invested in defense and high tech (notably biotech), space, security-linked information technology, nanotechnologies, and telecommunications. The companies it controls share the characteristic that their main customers are governments and administrations. As the company wrote in its brochure: “We invest in the opportunities created in industries strongly affected by changes in government policy.”

  Carlyle is a unique model, assembled at the planetary level on the capitalism of relationships or “capitalism of access” to use the 1993 expression of the American magazine New Republic. Today, in spite of its denials, the group incarnates the “military-industrial complex” against which Republican President Dwight Eisenhower warned the American people when he left office in 1961.

  That didn’t prevent George Bush senior from occupying a position as consultant to Carlyle for the ten years ending October 2003. It was the first time in United States’ history that a former president worked for a Pentagon supplier. His son, George W. Bush, also knows Carlyle well. The group found him a job in February 1990, while his father occupied the White House: administrator for Caterair, a Texas company specialized in aerial catering. The episode does not figure in the president’s official biography. When George W. Bush left Caterair in 1994, before becoming Governor of Texas, the company was in bad shape.

  “It’s not possible to get closer to the administration than Carlyle is,” asserts Charles Lewis, Director of the Center for Public Integrity, a non-partisan organization in Washington. “George Bush senior earned money from private interests that worked for the government of which his son was president. You could even say that the president could one day profit financially, through his father’s investments, from the political decisions he himself took,” he adds.

  The collection of influential characters who now work, have worked, or have invested in the group would make the most convinced conspiracy theorists incredulous. They include among others, John Major, former British Prime Minister; Fidel Ramos, former Philippines President; Park Tae Joon, former South Korean Prime Minister; Saudi Prince Al-Walid; Colin Powell, the present Secretary of State; James Baker III, former Secretary of State; Caspar Weinberger, former Defense Secretary; Richard Darman, former White House Budget Director; the billionaire George Soros, and even some bin Laden family members. You can add Alice Albright, daughter of Madeleine Albright, former Secretary of State; Arthur Lewitt, former SEC head; William Kennard, former head of the FCC, to this list. Finally, add in the Europeans: Karl Otto Poehl, former Bundesbank president; the now-deceased Henri Martre, who was president of Aerospatiale; and Etienne Davignon, former president of the Belgian Generale Holding Company.

Le Monde –  April 29, 2004

  Carlyle isn’t only a collection of power people. It maintains holdings in close to 200 companies and, above all, provides returns on its investments that have exceeded 30 % for a decade. “Compared to the five hundred people we employ in the world, the number of former statesmen is quite small, a dozen at most,” explains Christopher Ullmann, Carlyle Vice-President for communication. “We’re accused of every wrong, but no one has ever brought proof of any kind of misappropriation. No legal proceeding has ever been brought against us. We’re a handy target for whoever wants to take shots at the American government and the president.”

  Carlyle was created in 1987 in the salons of the New York eponymous palace, with five million dollars. Its founders, four lawyers, including David Rubenstein (a former Jimmy Carter advisor), had the -limited- ambition at the time of profiting from a flaw in fiscal legislation that authorized companies owned by Eskimos in Alaska to give their losses to profitable companies that would thus pay reduced taxes. The group vegetated until January 1989 and the arrival at its helm of the man who would invent the Carlyle system, Frank Carlucci. Former Assistant Director of the CIA, National Security Advisor, then Ronald Reagan’s Defense Secretary, Mr. Carlucci counted in Washington. He is one of current Defense Secretary Donald Rumsfeld’s closest friends. They were roommates as students at Princeton together. Later, their paths crossed in several administrations and they even worked for a time at the same company, Sears Roebuck.

  Six days after officially quitting the Pentagon, January 6, 1989, Frank Carlucci became Carlyle’s Director General. He brought trusted lieutenants from the CIA, the State Department, and the Defense Department with him. Nicknamed “Mr. Clean”, Frank Carlucci has a sulfurous reputation.

  This diplomat was posted during the 1970s to countries such as South Africa, the Congo, Tanzania, and Portugal, where the United States and the CIA had played a questionable political role. He was the number two at the American embassy in the Belgian Congo in 1961 and was suspected of being implicated in the assassination of Patrice Lumumba. He has always firmly denied it. The American press has also accused him of being implicated in several cases of arms trafficking in the 1980s, but he has never been prosecuted. For a while, he directed Wackenhut, a security company with a hateful reputation, implicated in one of the biggest espionage scandals ever, the hijacking of Promise software. Frank Carlucci had the mission of cleaning up after the Iran-Contra affair in the Reagan administration and he succeeded John Pointdexter as National Security Advisor. As he took over his new position, he chose a young general to be his assistant… Colin Powell.

  Frank Carlucci’s name attracted capital to Carlyle. In October 1990, the group took over BDM International, which participated in the “Star Wars” Program and constituted a bridgehead to it. In 1992, Frank Carlucci allied himself with the French group Thomson-CSF to take over LTV’s aerospace division. The operation failed, Congress opposing the sale to a foreign group. Carlyle found other associates, Loral and Northrop, and got hold of LTV Aerospace, quickly renamed Vought Aircraft, which contributed to the manufacture of the B1 and B2 bombers.

  At the same time, the fund was multiplying its strategic acquisitions, such as Magnavox Electronic Systems, a pioneer in radar imagery, and DGE, which owns the technology for cruise missile electronic relief maps.

  Three companies specializing in nuclear, chemical, and biological decontamination (Magnetek, IT Group and EG & G Technical Services) followed. Then, through BDM International, a firm linked to the CIA, Carlyle acquired Vinnell, which was among the first companies to supply the American army and its allies with private contractors, i.e. mercenaries. Vinnell’s mercenaries train the Saudi armed forces and protect King Fahd. During the first Gulf War, they fought alongside Saudi troops. In 1997, Carlyle sold BDM and Vinnell, which had become too dangerous. The group didn’t need it any more. It had become the Pentagon’s eleventh biggest supplier by gaining control of United Defense Industries that same year.

  Carlyle emerged from the shadows in spite of itself on September 11, 2001. That day, the group had organized a meeting at Washington’s Ritz Carlton Hotel with five hundred of its largest investors. Frank Carlucci and James Baker III played masters of ceremony. George Bush senior made a lightning appearance at the beginning of the day. The presentation was quickly interrupted, but one detail escaped no one. One of the guests wore the name bin Laden on his badge. It was Shafiq bin Laden, one of Osama’s many brothers. The American media discovered Carlyle. One journalist, Dan Briody, wrote a book about the group’s hidden side, “The Iron Triangle”, and takes an interest in the close relations between the Bush clan and the Saudi leadership.

  Some ask about George Bush senior’s influence on American foreign policy.

  In January 2001, while George Bush junior was breaking off negotiations over missiles with North Korea, the dismayed South Koreans intervened with his father. Carlyle has important interests in Seoul. In June 2001, Washington resumed discussions with Pyongyang.

  Another example: in July 2001, according to the New York Times, George Bush senior telephoned Saudi Prince Abdullah who was unhappy with the positions the president took on the Israeli-Palestinian conflict. George Bush senior reassured the prince that his son “is doing good things” and “has his heart in the right place.”

  Larry Klayman, Director of Judicial Watch, a resolutely conservative organization, demands that “the president’s father resign from Carlyle. The group has conflicts of interest that can create problems for American foreign policy.” Finally, in October 2003, George Bush senior leaves Carlyle, officially because he’s nearing eighty years old.

  It doesn’t matter that Carlyle put an end to all relations with the bin Laden family in October 2001; the evil was already done. The group, along with Halliburton, has become the target of Bush administration opponents.

  “Carlyle has replaced the Trilateral Commission in conspiracy theories,” David Rubenstein acknowledged in a 2003 Washington Post interview. For the first time, the group put someone in charge of communications and changed its boss. Frank Carlucci became honorary president and Lou Gerstner, a respected executive who saved IBM, officially took the reins.

  That operation seems mostly cosmetic. Mr. Gerstner doesn’t spend much time in his office; but Carlyle wants to become respectable.

  The Group has created an Internet site. It has opened certain funds to investors bringing “only” 250,000 dollars (210,000 euros). It will have reduced its holdings in United Defense Industries, and asserts that defense and aeronautics represent no more than 15 % of its investments.

  However, Carlyle continues to make intensive use of fiscal havens and it’s difficult to know the names of the companies it controls or its perimeter.

  Carlyle is also increasing its efforts in Europe. In September 2001, it took control of the Swedish weapons manufacturer Bofors through United Defense. Subsequently, it tried, unsuccessfully, to take over Thales Information Systems and, in the beginning of 2003, to acquire those parts of France Telecom that are in Eutelsat, which plays an important role in the European Positioning System by Galileo satellite – a competitor of the American GPS. From 1999 to 2002, it managed a holding in Le Figaro. In Italy, it made a breakthrough, by taking up Fiat’s aeronautics subsidiary, Fiat Avio. This company is a supplier to Arianespace and allows Carlyle to be part of the European Rocket Council. In another coup in December 2002, Carlyle bought a third of Qinetic, the private subsidiary of the British military’s Research and Development Center. Qinetic occupies a unique advisory role with the British government.

  “To anticipate the technologies of the future and the enterprises which will develop them is our first role as an investor. Pension funds bring us their money for that. You can’t blame us for trying to take strategic positions,” Mr. Ullmann stresses.

   Translation: t r u t h o u t French language correspondent Leslie Thatcher.

#1

WED, 04 DECEMBER 2002

Sale of a Stake in QinetiQ PLC to The Carlyle Group

2002-014

London – The Ministry of Defence has agreed the terms under which The Carlyle Group will become its strategic partner to assist in the future development of QinetiQ, Defence Minister Lewis Moonie announced today.

Dr Moonie said: “The strategic partnership with The Carlyle Group keeps QinetiQ on course to become a leading science and technology company that aspires to be the envy of the world. The Carlyle Group shares our vision for the future of QinetiQ and is well placed to support the management team in building a company, which we expect to flourish commercially, based on its commitment to excellence.”

“QinetiQ will remain a British company based in the UK. MOD will retain a Special Share in the business to ensure that the nation’s defence and security interests continue to be protected. There will also be robust safeguards to prevent conflicts of interest and to ensure that the integrity of the Government’s procurement process is not compromised”.

“This is good news for taxpayers, who will benefit from the immediate sale proceeds as well as from QinetiQ’s potential increase in value over time. And it is good news for QinetiQ’s employees who will have the opportunity to invest in the future of the business through a staff equity scheme and will each receive a small free allocation of share options. Today’s announcement marks a new future for science and technology in Britain.”

The sale follows MOD’s decision in March this year to seek a strategic partner to invest in QinetiQ, and the selection of The Carlyle Group as preferred bidder in September. The transaction values QinetiQ at around £500m. Following adjustments to reflect current assets and liabilities, MOD will receive between £140 and £150m from the transaction (the final amount will depend on the company’s exact financial position at completion), in addition to £50m already received from QinetiQ as part of the purchase price for its assets. Subject to the satisfactory fulfilment of a number of final conditions, formal completion of the sale process is expected early in the New Year,

Carlyle will acquire a 33.8% economic interest in QinetiQ with a further 3.7% of the shares to be made available for the employees. MOD’s retention of a 62.5% current stake in the business will ensure that the taxpayer shares in the benefits of the growth in QinetiQ, which we anticipate will follow the introduction of a strategic partner. The MOD plans to sell its entire stake in QinetiQ within 3-5 years, probably through a flotation on the stock market.

Management control and responsibility for setting future commercial strategy will now lie with QinetiQ and The Carlyle Group, allowing them to make appropriate decisions to grow the value of the business. MOD will retain those rights which are conventional for a major shareholder.

QinetiQ’s Board of Directors, chaired by Dame Pauline Neville-Jones, will be augmented by the appointment of two Carlyle nominees – Glenn Youngkin, a Managing Director of The Carlyle Group, and Sir Denys Henderson. MOD also has the right to appoint two non-executive directors.

Sir John Chisholm, QinetiQ’s Chief Executive commented: “Working together, QinetiQ and The Carlyle Group will be a strong team with complementary experience. We can now be even more confident of achieving our ultimate goal of moving from a European leader to a global technological solutions provider for our diverse range of customers. Carlyle’s investment secures a bright, long-term future for our business, our employees and our customers.”

Glenn Youngkin, The Carlyle Group’s Managing Director in London, commented: “We are impressed with the quality of the business and are looking forward to supporting such a capable and ambitious management team. We can see enormous opportunities to grow the value of the business, harnessing innovation to create profitable commercial applications.”

The Queen’s military-industrial QinetiQ Group Plc (adjacent to The Pirbright Institute) was founded in Nov. 11, 2002 by:

62%        UK Ministry of Defence (MOD) — UK

34%        The Carlyle Group — US

4%           QinetiQ employees

Note: On Nov. 08, 20023 days earlierSERCO Plc bought SI International, Inc. and changed SI International’s name to SERCO, Inc. which had already been being awards massive contracts with the U.S. Patent Office, FEMA, OMB, Navy SPAWAR, OPM, State Department, DoD, Army, Navy, FAA, FEC, etc.

SI international 1

On Dec. 09, 2002one month laterLeader Technologies’ patent attorney James P. Chandler, III, secretly merged CRYPTO.com with Markland Technologies. Markland was represented by Supreme Court Chief Justice John Roberts’ wife Jane Sullivan Roberts as director of Major, Lindsey  & Africa.

p.1

Carlyle 1
Carlyle 2
Carlyle 3

p.2

directors
chisholm

1.    Sir John Chisholm

  • https://en.wikipedia.org/wiki/John_Chisholm_(executive)
  • Medical Research Council, chairman
  • Qinetiz, chairman
  • Cambridge University
  • General Motors
  • British Petroleum (BP)
  • CAP Scientific
  • SEMA-METRA
  • DERA (UK Defence Evaluation and Research Agency)
  • House of Commons Public Accounts Committee, chairman
  • NESTA (National Endowment for Science Technology and the Arts), chairman
  • UK Electrical Engineering Association, president
  • QinetiQ. Director
henderson

2.  Sir Denys Henderson, Esq.

  • https://en.wikipedia.org/wiki/Denys_Henderson
  • Imperial Chemical Industries (ICI), chairman
  • S.G. Warburg
  • Goldman Sachs
  • Zeneca Group (AstraZeneca), chairman
  • Rank (Xerox), chairman
  • Dalgety, chairman
  • Crown Estates, chairman
  • Barclays, director
  • Rio Tinto Zinc, director
  • Schlumberger, director
  • MORI, director
  • AZ Electronic Materials, director
  • Qinetiq, director
  • The Carlyle Group, director
kruth

3.   Hal Kruth

  • https://www.linkedin.com/in/hal-kruth-5564289/
  • Stanford Research Institute (SRI), licensing
  • QinetiQ Group plc, director, president (US subsidiary)
  • Quintel Technology, director
  • QinetiQ Nanomaterials/Intrinsiq Materials, director
  • QinetiQ Rail – UK: Onboard broadband
  • Holographic Imaging, Inc.(QinetiQ joint venture with Ford Motor Company) – US: Holographic displays
  • Factor(E) Ventures, advisor
  • 42MORE, CEO
  • Sierra Angels
  • OTHER DIRECTORSHIPS
    • Sparkmeter Inc.- Washington DC based start-up: Smart meters
    • Waste Enterprisers, LLC- Africa based start-up: Biofuels
    • Glue Networks- California-based start-up: Software defined WAN
    • Aperia Technologies- San Francisco-based start-up: Automatic tire inflation device
    • Dynamite Data, LLC- Nevada-based start-up: E-commerce data
    • Driptech, Inc.- India-based start-up: Low cost drip irrigation systems
    • pSiVida Limited – Australia/pSiMedica Ltd – UK: Drug delivery technology
    • Sarnoff Corporation (wholly-owned subsidiary of SRI International) – US
    • Polyfuel, Inc. (SRI spin-off) – US: PEM fuel cells
    • Pangene Corporation (SRI spin-off) – US: Gene therapy
    • Discern Communications(SRI spin-off) – US: Enterprise data management
love

4.  Graham Love

neville jones

5.  Dame Pauline Neville-Jones

  • https://en.wikipedia.org/wiki/Pauline_Neville-Jones,_Baroness_Neville-Jones
  • BBC, governor
  • JIC (British Joint Intelligence Committee)
  • Minister of State for Security and Counter Terrorism
  • National Security Council (NSC, UK)
  • Special Representative to Business on Cyber Security
  • Oxford University
  • British Missions, Rhodesia, Singapore, Washington DC, Bonn
  • European Commission, Chef de Cabinet
  • Cabinet Office, head, Defence and Overseas Secretariat
  • Joint Intelligence Committee, chair
  • UK Foreign and Commonwealth Office (FCO), political director
  • Dayton Bosnia settlement, British delegation
  • Governors’ World Service Consultative Group, chair
  • QinetiQ, chair
  • Information Assurance Advisory Council, chair
  • Minister of State for Security and Counter Terrorism
  • Privy Council (2010-present)
symonds

6. Sir Jonathan Symonds, CBE

colin balmer

7. Colin Balmer

Youngkin

8. Glenn Youngkin


Mar. 31, 2009 Qinteiq Group of companies accounts

Qinteiq 1
Qinteiq 2
qinetiq 2
qinetiq 3
NASA
global capabilities
NASA 2
us uk
George Tenet, Qinetiq and the Monarch’s Golden Share

#2

#3

Guess Who Toasted George and Barbara Bush at Their 60th Wedding Anniversary Party?

EPJ – SUNDAY, JUNE 13, 2010

Laura Bush is out with her memoir, Spoken from the Pocketbook Heart.

Fed chairman Ben Bernanke doesn’t make it into the book, neither does Treasury Secretary during the GW  years, Hank Paulson. But what’s a White House memoir without a memory of  David Rubenstein, the co-founder of the private equity firm Carlyle Group, who made George H. W. hundreds of millions after he left the White House ?

Laura tells us that not only did Rubenstein show up at the White House for a 60th wedding anniversary party for George H.W. and Barbara Bush, but he gave the toast!

Rubenstein informed the onlookers during his toast that George and Barbara are the only couple who have lived in the White House and have celebrated a 60th wedding anniversary. Nice touch by David.

Laura describes David as a “long time friend.”  Translation: Anybody that can figure out how to exploit George’s connections for more money than any of them had ever seen before can certainly be a life long friend.

Look, Rubenstein on a personal level is a nice guy. Whenever I have spoken to him, he has always been polite to me. When I have asked him a question out of left field to throw him off, he tends to really spend time to think about the question and give me a thoughtful answer, but of all the people George and Barbara have met over the years, and some probably truly long-term friends, it is remarkable that Rubenstein, who is roughly 30 years younger than George H. W., is giving a toast at at the Bush’s 60th wedding anniversary.

#4

“I see Republicans…” – Klaus Schwab at Davos (jk)

#5

The Southern Poverty Law Center Is a Hate-Based Scam that Nearly Caused Me to Be Murdered

The Southern Poverty Law Center Is in a State of Moral Collapse

Southern Poverty Law Center Faces Racism, Corruption, Sexual Harassment Claims

Twelve Ways The Southern Poverty Law Center Is A Scam To Profit From Hate-Mongering

Making Hate Pay: The Corruption of the Southern Poverty Law Center

Exaggerating Hate Pays: Scandal-Plagued SPLC Has Millions in Offshore Accounts, Half a Billion in Assets

Youngkin’s CRT campaign ad: ‘A New Direction’

#6

#7

So it’s Klaus Schwab, The UK Royal Crown and The Rothschilds who won the gubernatorial elections in Virginia, as per normal. With technical and logistic support from The Military BioTech Complex, of course.

Youngkin at Davos 2020: Carlyle is all tuned up for ‘Stakeholder Capitalism’

update november 19, 2021: lol

BONUS

<<Pop singer Taylor Swift took another swing at billionaire investor George Soros on Thursday, condemning the “shameless greed” of the financier for partnering with her ex-manager Scooter Braun to release a new album of her songs.

Swift, who has emerged as an outspoken supporter of the Democratic Party, railed against Soros, a liberal megadonor, and Braun, who helped organize the March for Our Lives gun-control protest, after learning her former label Big Machine was releasing an album of a live radio concert she performed in 2008.

“It looks to me like Scooter Braun and his financial backers, 23 Capital, Alex Soros, and the Soros family and The Carlyle Group, have seen the latest balance sheets and realized that paying $330 million for my music wasn’t exactly a wise choice and they need money,” Swift wrote on Instagram. “In my opinion, just another case of shameless greed in the time of Coronavirus. So tasteless, but very transparent.”

Swift also attacked the Soros family in December as being the financial enablers of Braun’s takeover of her former label and her old music.

“After I was denied the chance to purchase my music outright, my entire catalog was sold to Scooter Braun’s Ithaca Holdings in a deal that I’m told was funded by the Soros family, 23 Capital, and the Carlyle Group,” Swift said at Billboard’s “Women in Music” event. “Yet to this day, none of these investors have bothered to contact me or my team directly to perform their due diligence on their investment, on their investment in me.” >> – The Washington Free Beacon

To be continued?
Our work and existence, as media and people, is funded solely by our most generous readers and we want to keep this way.
Help SILVIEW.media survive and grow, please donate here, anything helps. Thank you!

! Articles can always be subject of later editing as a way of perfecting them

ORDER